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Aeromonas spp. are primary organisms of normal aquatic microflora, and recently, there 
has been an increasing appreciation of their role as waterborne pathogens of fish and 
humans. Aeromonas hydrophila is a motile aeromonad that can cause disease in fish, 
resulting in high rates of mortality wherever outbreaks occur. There has been an increasing 
incidence of antimicrobial resistance among Aeromonas sp. isolated from aquaculture 
environments. Multiple-antibiotic-resistant A. hydrophila exists in aquaculture systems and 
contributes to the high rate of mortality within the fish industry in Korea. Although the 
majority of the loach population in Korea is cultured and A. hydrophila is one of the main 
causes of mass mortality in these fish, no effective method has been proposed for the 
control of A. hydrophila infection in aquaculture, except for the application of additional 
antibiotics. To investigate methods to control the mass mortality of cyprinid loaches 
(Misgurnus anguillicaudatus) caused by multiple-antibiotic-resistant Aeromonas 




and pAh6-C, were isolated from the Han River in Seoul. The two isolated phages were 
morphologically classified as Myoviridae and showed similar infection patterns for A. 
hydrophila isolates. The two phages possessed approximately 55 kb (pAh1-C) and 58 kb 
(pAh6-C) of double-stranded genomic DNA, and their gDNAs showed different restriction 
endonuclease digestion patterns. Both phages showed efficient bacteriolytic activity 
against fish-pathogenic A. hydrophila from loaches. The latent periods of the phages were 
estimated to be approximately 30 min (pAh1-C) and 20 min (pAh6-C), while the burst 
sizes were 60 PFU/cell (pAh1-C) and 10 PFU/cell (pAh6-C). The phages proved to be 
efficient in the inhibition of bacterial growth, as demonstrated by their in vitro bactericidal 
effects. Additionally, a single administration of either phage to cyprinid loaches resulted in 
noticeable protective effects, with increased survival rates against A. hydrophila infection. 
These results suggest that the phages pAh1-C and pAh6-C constitute potential therapeutic 
agents for the treatment of A. hydrophila infection in fish.  
Vibrio parahaemolyticus is one of the most important causes of gastroenteritis. It is 
associated exclusively with the consumption of raw or improperly cooked contaminated 
seafood, especially oysters. V. parahaemolyticus is recognized as an important human 
pathogen globally. East Asians, especially Koreans and Japanese consume a unique diet. 
Koreans enjoy a wide variety of both raw finfish and shellfish. Although raw oysters have 
such high densities of V. parahaemolyticus that the consumption of raw oysters is known to 
cause illness in humans, almost all Koreans prefer raw oysters to already cooked oysters 
because of their fresh taste and high nutritional value. V. parahaemolyticus pandemic 
strains, such as O3:K6, are responsible for the current pandemics in many countries. 
Emergence of Vibrio species that are resistant to multiple antibiotics has been recognized 




strains have displayed multiple antibiotic resistance, increasing concerns about possible 
treatment failure. Alternatives to conventional antibiotics are needed, especially for the 
multiple-antibiotic-resistant V. parahaemolyticus pandemic strain. A bacteriophage, 
designated pVp-1, that was lytic for V. parahaemolyticus was isolated from the coast of the 
Yellow Sea in Korea. The phage showed effective infectivity for multiple-antibiotic-
resistant V. parahaemolyticus and V. vulnificus, including V. parahaemolyticus pandemic 
strains. The therapeutic potential of the phage was studied in a mouse model of 
experimental infection using a multiple-antibiotic-resistant V. parahaemolyticus pandemic 
strain. Phage-treated mice displayed protection from a V. parahaemolyticus infection and 
survived lethal oral and intraperitoneal bacterial challenges. This is the first report, to the 
best of the knowledge, of phage therapy in a mouse model against a multiple-antibiotic-
resistant V. parahaemolyticus pandemic strain infection. 
The complete genome sequence of a novel marine siphovirus pVp-1, which was 
isolated from the coastal water of the Yellow sea in Korea and infects V. parahaemolyticus, 
was reported. The double-stranded DNA genome of pVp-1 is composed of 111 kb with a G 
+ C content of 39.71%. The genome encodes a total of 157 ORFs. Genome sequence 
analysis of pVp-1 and comparative analysis with the homologous phage T5 revealed that 
there is a degree of similarity between pVp-1 and T5, thus indicating a close genetic 
relatedness between pVp-1 and T5. Genomic comparison of pVp-1 with the phage T5 
revealed that these two phages are highly similar in gene inventory. 
Based on these results, it can be concluded that Aeromonas phages that infect antibiotic-
resistant A. hydrophila strains could be considered as alternative therapeutic or 
prophylactic candidtates against Aeromonas infections in aquaculture. In addition, phage 




the application of pVp-1 can protect from a V. parahaemolyticus infection, and pVp-1 can 
be used as a therapeutic agent to reduce the impact of epidemics caused by multiple-
antibiotic-resistant pandemic strains. 
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Multiple-antibiotic-resistant pandemic strains, Therapeutic agent. 
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The genus Aeromonas is a member of the family Aeromonadaceae that are primarily 
aquatic organisms found in water. Some Aeromonas sp. are pathogenic for humans as well 
as fish (27). The organisms in this family produce a clear zone of β-hemolysis on blood 
agar (11). A. hydrophila is a member of motile aeromonads and it can cause disease in fish, 
resulting in high mortality (1, 2, 5, 6, 18). There has been an increasing incidence of 
antimicrobial resistance among Aeromonas sp. isolated from aquaculture environments (24, 
25, 26). Five classes of genetically distinguishable tetracycline resistance determinants, 
designated A through E, have been described among aerobic enteric gram-negative bacteria 
(20). Several studies have shown tetE to be the predominant determinant among the 
different classes of tetracycline-resistant genes (4, 19, 25). 
The loach (Misgurnus spp.) is a member of the Cobitidae family (Lacepede, 1803) and 
inhabits freshwater systems by nature (13). Two species of loaches (Misgurnus spp.), the 
mud loach (M. mizolepis) and the cyprinid loach (M. anguillicaudatus), are cultured mostly 
for food and sometimes for Buddhism ceremonies in Korea (12). The annual demand for 
loaches in Korea and Japan was over 100,000t in 2004 due to its high nutritional value and 
use in folk medicine (8). Aquaculture of loach in 2008 was over 432t in Korea (14). 
Jeollabuk-do province in Korea is famous for the aquaculture of loaches, with over 384t in 
2008, which was 89% of the total loach aquaculture in the entire country (7). 
There have been few reports about A. hydrophila in Korea since the previous 
publication about isolation of A. hydrophila from rainbow trouts in Korea (16). Although 
the majority of the loach population is cultured and A. hydrophila is one of the main causes 





Vibrio parahaemolyticus is one of the most important causes of gastroenteritis (3). It is 
associated exclusively with the consumption of raw or improperly cooked contaminated 
seafood, especially oysters (3). V. parahaemolyticus is recognized as an important human 
pathogen globally (3, 9, 22). According to the official statistics issued by the Korea Food 
and Drug Administration (10), V. parahaemolyticus is one of the most common causes of 
food-borne disease in Korea, and caused 17 outbreaks with a total of 663 patients in 2005, 
25 outbreaks (547 patients) in 2006, 33 outbreaks (634 patients) in 2007, 24 outbreaks 
(329 patients) in 2008, and 12 outbreaks (106 patients) in 2009. 
East Asians, especially Koreans and Japanese consume a unique diet. Koreans enjoy a 
wide variety of both raw finfish and shellfish. Although raw oysters have such high 
densities of V. parahaemolyticus that the consumption of raw oysters is known to cause 
illness in humans (3), almost all Koreans prefer raw oysters to already cooked oysters 
because of their fresh taste and high nutritional value. Also, seafood cross-contaminated 
with raw oyster can cause high risk for V. parahaemolyticus infections in the United States 
(3). In Korea especially, all seafood in fishery markets, including oysters, is sold in the 
same seawater and tanks, causing cross-contamination. 
Virulence of V. parahaemolyticus is commonly associated with the tdh and trh genes, 
encoding thermostable direct haemolysin (TDH) and tdh-related haemolysin (TRH), 
respectively (15). Open reading frame 8 (ORF8) is considered as a potential factor causing 
epidemics and a genetic marker for V. parahaemolyticus O3:K6 strains (23). V. 
parahaemolyticus pandemic strains such as O3:K6 strains exhibit a unique toxRS sequence 
responsible for the current pandemic in many countries (17). 




Emergence of microbial resistance to multiple drugs is a serious clinical problem in the 
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A. Aeromonas hydrophila 
 
A.1. Perspective of Aeromonadaceae 
The genus Aeromonas (Kingdom, Bacteria; Phylum, Proteobacteria; Class, 
Gammaproteobacteria; Order, Aeromonadales; Family, Aeromonadaceae) has undergone a 
number of taxonomic and nomenclature revisions in the past. Although originally placed in 
the family Vibrionaceae (104), which also included the genera Vibrio, Photobacterium, and 
Plesiomonas, subsequent phylogenetic investigations indicated that the genus Aeromonas 
is not closely related to vibrios but rather forms a monophyletic unit in the gamma-3 
subgroup of the class Proteobacteria (63, 89). These conclusions necessitated the removal 
of Aeromonas from the family Vibrionaceae and transfer to a new family, the 
Aeromonadaceae (20). Similarly, only five species of Aeromonas were recognized 25 years 
ago (47), three of which (A. hydrophila, A. sobria, and A. caviae) existed as phenospecies, 
that is, a named species containing multiple DNA groups, the members of which could not 
be distinguished from one another by simple biochemical characteristics. Subsequent 
systematic investigations have resulted in the number of valid published genomospecies 
rising to 14 (50), and it is anticipated that additional species will be described because rare 
strains have been identified that do not reside in any established Aeromonas species. 
Except for one species, A. salmonicida, they are motile by means of a single polar 
flagellum. On the other hand, approximately 30 motile Aeromonas spp. (A. 




diversa, A. encheleia, A. enteropelogenes, A. eucrenophila, A. fluvialis, A. hyrophila, A. 
jandaei, A. media, A. molluscorum, A. piscicola, A. popoffii, A. rivuli, A. sanarellii, A. 
sharmana, A. schubertii, A. simiae, A. taiwanensis, A. tecta, A. trota, A. veronii biovar 
sobria, and A. veronii biovar veronii) were identified and those species have been 
associated with various human infections such as gastro-enteritis and wound infections, 
causing primary and secondary septicemia in immunocompromised persons (31), and have 
also been implicated as the causative agents of various fish diseases (49). 
 
A.2. Aeromonadaceae species 
From the creation of the genus Aeromonas in 1943 through the mid-1970s, aeromonads 
could be broken down roughly into two major groupings, based upon growth 
characteristics and other biochemical features (47). The mesophilic group, typified by A. 
hydrophila, consisted of motile isolates that grew well at 35 to 37 °C and were associated 
with a variety of human infections. The second group, refered to as psychrophilic strains, 
caused diseases in fish, wers nonmotile, and had optimal growth temperatures of 22 to 
25 °C. This group contained isolates that currently reside within the species A. salmonicida. 
Beginning in the mid-1970s and continuing for almost 10 years thereafter, several 
groups, including the Institut Pasteur in Paris, the Centers for Disease Control and 
Prevention (CDC) in Atlanta, GA, and the Walter Reed Institute of Research in Washington, 
DC, spearheaded an effort to redefine the mesophilic group based upon DNA relatedness 
studies. Over that span of time, DNA hybridization investigations revealed that multiple 
hybridization groups (HGs) existed within each of the recognized mesophilic species (A. 
hydrophila, A. sobria, and A. caviae) (30, 84). These unnamed HGs were represented by 




other by simple biochemical means. 
 
A.3. Aeromonas and ecosystems 
Aeromonds are essentially ubiquitous in the microbial biosphere. They can be isolated 
from virtually every environmental niche where bacterial ecosystems exist. These include 
aquatic habitats, fish, foods, domesticated pets, invertebrate species, birds, ticks and insects, 
and natural soils, although extensive investigations on the latter subject are lacking. The 
vast panorama of environmental sources from which aeromonads can be encountered lends 
itself readily to constant exposure and interactions between the genus Aeromonas and 
humans. 
The relative environmental distributions of Aeromonas species in selected settings, as 
currently known, are presented in previous publications. Earlier studies have indicated that 
three Aeromonas genomospecies (A. hydrophila, A. caviae, and A. veronii bv. sobria) are 
responsible for the vast majority (> 85%) of human infections and clinical isolations 
attributed to this genus (46). The same pattern observed clinically appears to repeat itself in 
most environmental samples, with A. salmonicida included as a predominant species in 
fish and water samples. In some studies, less frequently encountered species have been 
found to predominate in environmental samples, such as A. schubertii in organic 
vegetables (67). For newly described species such as A. aquariorum and A. tecta, no data 
exist on their relative distributions in the environment outside their initial taxonomic 
description, and extremely limited data are available on many other taxa described since 
2004. Finally, the techniques and methods used to identify Aeromonas isolates to the 





A.4. Virulence factors of Aeromonas 
Virulence of Aeromonas sp. is multifactorial and not completely understood (29). 
Aeromonas sp. have been reported to elaborate exotoxins (hemolysins, cytotoxins, and 
enterotoxins), hemagglutinins, adhesins, several hydrolytic enzymes, and invade tissue in 
culture (10, 36, 45, 57). The hemolysin produced by some Aeromonas sp. (also known as 
aerolysin) has been shown to have both hemolytic and enterotoxic activity (5, 16). Burke et 
al. (9) found that 97% of the hemolysin-producing strains were able to secrete enterotoxins. 
Other investigators also reported a correlation between hemolysin and cytotoxin 
production (82). The hemolytic enterotoxin shares significant homology with the cytotoxic 
enterotoxin (Act), and two cytotonic toxins (Alt and Ast) (19). Rahim et al., (85) tested 32 
act gene probe-positive and 31 randomly selected act gene probe-negative Aeromonas 
isolates for enterotoxicity in a suckling mice assay (SMA), for haemolytic activity on 
sheep blood agar plates, for the presence of CAMP-like factors, and for cytotoxicity in a 
Vero cell line. This study indicated the role of Act in the pathogenesis of Aeromonas 
infections and that the enterotoxic potential of Aeromonas sp. could be assessed by simply 
performing a CAMP-haemolysin assay. 
Enterotoxigenic isolates of A. hydrophila showed hemagglutination (HA) which was 
not sensitive to mannose (i.e. mannose-resistant [MRHA]) and fucose, but Aeromonas 
strains that were HA-sensitive to mannose or showed no hemagglutination (NHA) were 
non-toxic strains of A. caviae commonly isolated from nondiarrhoeal infection ot the 
environment (10). In enteric bacteria, hemagglutination of erythrocytes is associated with 






A.5. Aeromonas and aquatic environments 
Groundbreaking studies conducted over 30 years ago by Terry Hazen and associates 
identified viable Aeromonas in 135 of 147 (91.8%) natural aquatic habitats sampled in the 
United States and Puerto Rico (38). Aeromonas numbers were higher in lotic than in lentic 
systems and were higher in thermal gradients ranging from 25 to 35 °C (38, 39). A. 
hydrophila grew over a wide range of temperatures, conductivities, pHs, and turbidities, 
with only those habitats with extreme ranges of these parameters (extremely saline 
environments, thermal springs, and highly polluted waters) failing to yield aeromonads. 
Today, the genus Aeromonas is considered to be almost synonymous with water and 
aquatic environments, being isolated from rivers, lakes, ponds, seawaters (estuaries), 
drinking water, groundwater, wastewater, and sewage in various stages of treatment. 
Concentrations of aeromonads in these sites have been reported to vary from lows of <1 
CFU/ml (groundwater, drinking water, and seawater) to highs of 108 CFU/ml or more, in 
crude sewage or domestic sewage sludge (41). Although primarily a freshwater resident, 
Aeromonas species can be recovered from the epipelagic layer (<200 m) of the ocean (as 
opposed to benthic regions), most often in estuaries, existing as free-living bacteria or in 
association with crustaceans. Estuaries are ideally suited for aeromonads, since salinity 
concentrations are substantially lower there than in the deeper (benthic) regions of the 
ocean. One study from the Italian coast found aeromonad numbers varying from 102 to 106 









A.6. Aeromonas and fish diseases 
The role of aeromonads as a causative agent of fish diseases has been known for 
decades, longer than their comparable role in causing systemic illnesses in humans. Two 
major groups of fish diseases are recognized. A. salmonicida causes fish furunculosis, 
particularly in salmonids. The disease has several presentations, ranging from an acute 
form characterized by septicemia with accompanying hemorrhages at the bases of fins, 
inappetence, and melanosis to a subacute to chronic variety in order fish, consisting of 
lethargy, slight exophthalmia, and hemorrhaging in muscle and internal organ (6). 
Mesophilic species (A. hydrophila and A. veronii) cause a similar assortment of diseases in 
fish, including motile Aeromonas septicemia (hemorrhagic septicemia) in carp, tilapia, 
perch, catfish, and salmon, red sore disease in bass and carp, and ulcerative infections in 
catfish, cod, carp, and goby (49). Mesophilic Aeromonas species, most notably A. 
hydrophila, have been linked to major die-offs and fish kills around the globe over the past 
decade, resulting in enormous economic losses. These die-offs included over 25,000 
common carp in the St. Lawrence River in 2001 (71), 820 tons of goldfish in Indonesia in 
2002, resulting in a 37.5 million dollars loss, and a catfish die-off in Minnesota and North 
Dakota in 2007. In many of these instances, Aeromonas species were sole or copathogens 
causing invasive secondary infections in immunosuppressed fish due to spawning or 
environmental triggers, such as high temperatures or low water levels. 
 
A.7. Antimicrobial resistance 
In the last two decade, high rates of resistance to commonly used, cheap oral antibiotics 
among enteric pathogens has been reported from several developing countries (86, 91, 




clinical sources and to a lesser extent from foods and water. The ease of which 
antimicrobial agents can be obtained in these countries has been blamed for this problem 
(2, 90). High resistance rates to antimicrobial agents appear to be common among 
aeromonads isolated from fish in developing countries. Antimicrobial agents are used 
extensively in fish farms to treat and prevent fish diseases and also as feed additives. Such 
practice has been shown to increase drug resistant bacteria as well as R plasmids (37, 108). 
However, variation in the resistance rates of aeromonads to different antimicrobial agents 
in different developing countries can be observed. Such differences in the frequency of 
resistance may well be related to the source of the Aeromonas isolates and the frequency 
and type of antimicrobial agents prescribed for treating Aeromonas infections in different 
geographical areas (97). 
Resistance of most aeromonads to ampicillin is generally considered to be intrinsic or 
chromosomal mediated (4). Several studies have shown that patients taking ampicillin for 
reasons other than diarrhoea may predispose them to infection with Aeromonas (33, 72). 
Moyer (72) reported that for the susceptible host, antibiotic therapy, and drinking of 
untreated water are two significant risk factors for infection with Aeromonas. However, 
gastrointestinal infections with Aeromonas are generally self-limiting. Although treatment 
of patients with symptoms of infectious diarrhea with antibiotics remains controversial, 
antimicrobial therapy should be initiated for those who are severely ill and for patients 
with risk factors for extraintestinal spread of infection after obtaining appropriate blood 
and fecal cultures (40). The current accepted treatment of all acute infectious diarrhoeal 





B. Vibrio parahaemolyticus 
 
B.1. Perspective of Vibrio 
The genus Vibrio (Kingdom, Bacteria; Phylum, Proteobacteria; Class, 
Gammaproteobacteria; Order, Vibrionales; Family, Vibrionaceae) has played a significant 
role in human history. Outbreaks of cholera, caused by Vibrio cholerae, can be traced back 
in time to early recorded descriptions of enteric infections. Indeed, the path of human 
history has been influenced significantly by this organism (83, 107, 109). First described 
by Pacini (80) while he was a medical student in Italy and at a time when the germ theory 
of disease was in dispute, V. cholerae was subsequently identified and described in greater 
detail by Robert Koch (54, 55), to whom credit for the discovery of the causative agent of 
cholera traditionally has been given. 
The germ theory of disease was developed in the 19th century, based on the British 
queen’s physician John Snow’s tracing an 1849 cholera outbreak to a single contaminated 
well in the Broad Street area of central London; it remains a canonical example of 
epidemiology. Snow’s demonstration was an important mile-stone in public health, 
correctly identifying the fecal-oral route to human infection and offering powerful 
arguments for the germ theory (96). Many advances in the prevention and treatment of 
infectious diseases during the latter half of the 19th century and the first half of the 20th 
century follow directly from the acceptance of Snow’s point of view. 
The vibrios have also received the attention of marine microbiologists who observed 
that the readily cultured bacterial populations in near-shore waters and those associated 
with fish and shellfish were predominantly Vibrio spp. For example, the “gut group” 




Scotland. Fish diseases caused by vibrios have been reviewed extensively by marine 
investigators and, among the many fish pathogens, Vibrio anguillarum has been recognized 
historically as a major pathogen of marine animals. 
 
B.2. Viewpoint of Vibrio parahaemolyticus 
Vibrio parahaemolyticus is a Gram-negative, halophilic asporogenous rod that is 
straight or has a sinple, rigid curve. It has a single polar flagellum and is motile when 
grown in liquid medium (7). This bacterium is a human pathogen that occurs naturally in 
the marine environments and frequently isolated from a variety of seafoods including 
codfish, sardine, mackerel, flounder, clam, octopus, shrimp, crab, lobster, crawfish, scallop, 
and oyster (60). Consumption of raw or undercooked seafood, particularly shellfish, 
contaminated with V. parahaemolyticus may lead to development of acute gastroenteritis 
characterized by diarrhea, headache, vomiting, nausea, abdominal cramps, and low fever. 
This bacterium is recognized as the leading cause of human gastroenteritis associated with 
seafood consumption in the United States and an important seafood-borne pathogen 
throughout the world (53). 
Although the gastroenteritis caused by V. parahaemolyticus infection is often self-
limited, the infection may cause septicemia that is life-threatening to people having 
underlying medical conditions such as liver disease or immune disorders. Two deaths were 
among three cases of wound infections caused by V. parahaemolyticus in Louisiana and 








B.3. Occurrence of Vibrio parahaemolyticus 
The distribution of V. parahaemolyticus in the marine environments is known to relate 
to the water temperatures. Studies have shown that the organism was rarely detected in 
seawater until water temperatures rose to 15 °C or higher. Ecological study of V. 
parahaemolyticus in the Chesapeake Bay of Maryland found that V. parahaemolyticus 
survived in sediment during the winter and was released from sediment into water column 
when water temperatures rose to 14 °C in late spring or early summer (51). Another survey 
of nine U.S. coastal states conducted between 1984 and 1985 reported an average low 
density of V. parahaemolyticus in seawater when water temperatures dropped below 16 °C 
(26). However, the densities of V. parahaemolyticus in seawater could increase when water 
temperatures increased to around 25 °C (26, 51). A recent study of occurrence of V. 
parahaemolyticus in Oregon oyster-growing environments between November 2002 and 
October 2003 also found a positive correlation between V. parahaemolyticus in seawater 
and water temperatures with the highest populations of V. parahaemolyticus in water being 
detected in the summer months (24). 
The degree of V. parahaemolyticus contamination in raw shellfish is also known to 
relate to the water temperatures. Therefore, it is more likely to detect V. parahaemolyticus 
in oysters harvested in the spring and the summer than in the winter. V. parahaemolyticus 
can multiply rapidly in oysters upon exposure of elevated temperatures. Studies have 
shown that populations of V. parahaemolyticus in unrefrigerated oysters could increase 
rapidly to 50-790 folds of its original level within 24 h of harvest if oysters were exposed 
to 26 °C (35). A survey of 370 lots of oysters sampled from restaurants, oyster bars, retail 
and wholesale seafood markets throughout the US between June 1998 and July 1999 found 




detected in the summer months (21). 
 
B.4. Incidence of V. parahaemolyticus food poisoning 
V. parahaemolyticus was first recognized as a cause of food-borne illness on Osaka, 
Japan in 1951 (23). It caused a major outbreak of 272 illness and 20 deaths associated with 
consumption of sardines. Since then, V. parahaemolyticus has been reported to account for 
20-30% of food poisoning cases in Japan (1) and identified as a common cause of seafood-
borne illness in many Asian countries (17, 25, 110). V. parahaemolyticus was the leading 
cause of food poisoning (1710 incidents, 24,373 cases) in Japan between 1996 and 1998 
(44) and accounted for 69% (1028 cases) of total bacterial foodborne outbreaks (1495 
cases) reported in Taiwan between 1981 and 2003 (3) and 31.1% of 5770 foodborne 
outbreaks occurred in China between 1991 and 2001 (61). 
In contrast to Asian countries, V. parahaemolyticus infections are rarely reported in 
European countries. However, sporadic outbreaks have been reported in countries such as 
Spain and France. Eight cases of V. parahaemolyticus gastroenteritis related to fish and 
shellfish consumption were reported in Spain in 1989 (70). An outbreak of 64 illnesses 
associated with raw oysters consumption occurred in 1999 in Galicia, Spain (62). A serious 
outbreak affecting 44 patients associated with consumption of shrimps imported from Asia 
accurred in France in 1997 (88). A more recent outbreak involving 80 illnesses of V. 
parahaemolyticus infection among guests attending weddings in one restaurant was 
reported in Spain in July 2004 (64). Epidemiological investigation associated the outbreak 
with consumption of boiled crab that had been processed under unhealthy conditions. 
V. parahaemolyticus was first identified as an etiological agent in the US in 1971 after 




cooked crabs occurred in Maryland (69). Since then, sporadic outbreaks of V. 
parahaemolyticus infections related to consumption of raw shellfish or cooked seafood 
were reported throughout the US coastal regions. Between 1973 and 1998, approximately 
40 outbreaks of V. parahaemolyticus infections were reported to the Centers for Disease 
Control and Prevention (CDC) (22). Among them, four major outbreaks involving more 
than 700 cases of illness associated with raw oyster consumption occurred in the Gulf 
Coast, Pacific Northwest, and Atlantic Northeast regions between 1997 and 1998. In the 
summer of 1997, 209 cases (including one death) of V. parahaemolyticus infections 
associated with raw oyster consumption occurred in the Pacific Northwest (Oregon, 
Washington, California and British Columbia of Canada) (12). In 1998, two outbreaks 
occurred in Washington (43 cases) and Texas (416 cases) were associated with 
consumption of raw oyster (27). In addition, a small outbreak of eight cases of V. 
parahaemolyticus infections was reported in Connecticut, New Jersey, and New York 
between July and September in 1998 as a result of eating oysters and clams harvested at 
Long Island Sound of New York (13). Recently, 14 passengers on board a cruise ship in 
Alaska developed gastroenteritis after eating raw oysters produced in Alaska in the 
summer of 2004 (66). More recently, an outbreak of V. parahaemolyticus involving 177 
cases occurred in the summer of 2006 was linked to contaminated oysters harvested in 
Washington and British Columbia (15). The occurrence of these outbreaks indicates that 









B.5. Virulence factors 
It is known that most strains of V. parahaemolyticus isolated from the environment or 
seafood are not pathogenic (77). Clinical strains of V. parahaemolyticus are differentiated 
from environmental strains by their ability to produce a thermostable direct hemolysin 
(TDH), an enzyme that can lyse red blood cells on Wagatsuma blood agar plates. The 
hemolytic activity of TDH, named the Kanagawa phenomenon, has been reported to be 
commonly associated with strains isolated from humans with gastroenteritis but were 
rarely observed in environmental isolates (48). Therefore, the TDH has been recognized 
the major virulence factor of V. parahaemolyticus (68, 100). 
Despite epidemiological investigations revealed a strong tie between the Kanagawa 
phenomenon (KP) and the pathogenicity of V. parahaemolyticus, KP-negative strains that 
did not produce TDH but a TDH-related hemolysin (TRH) had been isolated from outbreak 
patients (42, 43). Shirai et al. (92) examined 215 clinical strains of V. parahaemolyticus 
isolated from patients with diarrhea for presence of genes encoding TDH (tdh) and TRH 
(trh) and found that 52 strains (24.3%) carried only the trh gene. These results indicate that 
TRH is also a virulence factor of V. parahaemolyticus. The genes encoding TDH (tdh) and 
TRH (trh) have been cloned and sequenced (52, 75, 101). Oligonucleotide probes for both 
tdh and trh genes have been developed for detection of virulent strains of V. 
parahaemolyticus (52, 76). 
 
B.6. Pandemic strains of V. parahaemolyticus 
Most outbreaks of V. parahaemolyticus infections were caused by V. parahaemolyticus 
of diverse serotypes. However, increased incidences of gastroenteritis caused by V. 




34, 64, 106). This serovar was first identified during a hospital-based active surveillance 
study of V. parahaemolyticus infections in Calcutta, India between 1994 and 1996 (79). 
The survet identified a sudden increase in incidences associated with this serovar, which 
accountered for 63% of total V. parahaemolyticus strains isolated from patients in Calcutta 
between September 1996 and April 1997. This highly virulence strain was subsequently 
recovered at a high rate in other Southeast Asian countries and was isolated from travelers 
arriving in Japan from various countries in the Southeast Asia (18, 79 106). 
V. parahaemolyticus O3:K6 was first identified in the US in 1998 and caused the largest 
outbreak (416 person) associated with oyster consumption in the US history (23). The 
same serovar wa later involved in another outbreak related to shellfish consumption in 
Connecticut, New Jersey, and New York (13). Since then, a pandemic spread of this clone 
to other continents has been reported. In 2004, V. parahaemolyticus O3:K6 was isolated 
from victims of outbreaks occurred in Chile (34) and Spain (64). The isolation of the 
O3:K6 strain from US outbreaks raised concern about increased risks of V. 
parahaemolyticus infections from US consumption. However, this serovar has not been 









C. Bacteriophage (phage) 
 
C.1. General description 
Phages are viruses that invade bacterial cells and, in the case of lytic phages, disrupt 
bacterial metabolism and cause the bacterium to lyse. They were discovered by Ernest 
Hankin (1896) and Frederick Twort (1915) who described their antibacterial activity. 
However, Felix d’Herelle (1919) was probably the first scientist who used phages as a 
therapy to treat severe dysentery. At that time, several companies then actively started up 
the commercial production of phages against various bacterial pathogens for human use. 
However, phage production was quickly displaced by the discovery of antibiotics in most 
of the Western world. Nevertheless, phage therapy is still an on-going practice in Eastern 
Europe and countries from the former Soviet Union. Several institutions in these countries 
have been involved in phage therapy research and production, with activities centralized at 
the Eliava Institute of Bacteriophage, Microbiology and Virology (Tbilisi, Georgia) and the 
Hirszfeld Institute of Immunology and Experimental Therapy (Wroclaw, Poland). Their 
work in this field has recently been extensively reviewed (56).  
The current threat of antibiotic-resistant bacteria has renewed the interest in exploring 
phages as biocontrol agents in Western countries (65, 98). In fact, some products based on 
phages are already commercially available (‘PhageBioderm’, ‘Bacteriophagum Intestinalis 
Liquidum’, ‘Pyobacteriophagum Liquidum’). Additionally, some care centers are 
particularly specialized in phage therapy (for example, Southwest Regional Wound Care 
Center, Texas). 
Besides phage therapy, the use of phages as antimicrobial agents and tools for detecting 




created recently (Table I).  
 
Table I. Companies involved in phage application. 
Company Country Website 
BIOphage PHARMA inc. Canada http://www.biophagepharma.net 
BIOPHARMA LIMITED Georgia http://www.biopharmservices.com 
CJ CheilJedang Korea http://www.cj.co.kr 
CTCBIO INC. Korea http://www.ctcbio.com 
MICREOS Food Safety Netherlands http://www.ebifoodsafety.com 
Exponential Biotherapies Inc. European Union http://www.expobio.com 
GangaGen, Inc. European Union http://www.gangagen.com 
Hexal-gentech Germany http://www.hexal-gentech.com 
Intralytix, Inc. European Union http://www.intralytix.com 
Komipharm International Co. Korea http://komilab.com 
Novolytics United Kingdom http://www.novolytics.co.uk 
Omnilytics, Inc. European Union http://www.phage.com 
Phage Biotech Ltd. Israel http://www.phage-biotech.com 
 
Fields of application comprise of water and food safety, agriculture and animal health. 
An example is OmniLytics, Inc. that gained US Environmental Protection Agency approval 
for the use of its product AgriPhage against plant pathogenic bacteria. In food 
manufacturing industry, EBI Food Safety recently marketed ListexTM P100 for controlling 
Listeria in meat and cheese products (11). In August 2006, the US Food and Drug 
Administration (FDA) approved the use of a phage preparation targeting Listeria, LMP 







C.2. Phage application in aquaculture 
Cultured fish and shellfish, like other animals and humans, are constantly threatened by 
microbial attacks. Although chemotherapy is a rapid and effective method to treat or 
prevent bacterial infections, frequent use of chemotherapeutic agents has allowed drug-
resistant strains of bacteria to develop. In particular, this problem in chemotherapy may be 
serious in fishery industries (74). Needless to say, vaccination is an ideal method for 
preventing infectious diseases, but commercially available vaccines are still very limited in 
the aquaculture field. This is partly due to the fact that many different kinds of infectious 
diseases occur locally in a variety of fish and shellfish species. Studies on biological 
control such as probiotics have been sporadically reported in the field of fish pathology (28, 
78, 105); however, they involve substantial difficulties in scientific demonstration of the 
causal sequence, as mentioned in human use of probiotics (102). In view of a scientific 
demonstration of phage treatment, the causal effect of phages in successful phage therapy 
can be definitively proven by confirming an increase in phage particles in the number or 
the presence of phages in the survivors, which is the result of the death of host bacterial 
cells. The feasibility of this demonstration distinguishes phage treatment from other 
biological controls, which fail to utilize scientific methodology in demonstrating causal 
relationships. Under these circumstances, phages, as specific pathogen killers, could be 
attractive agents for controlling fish bacterial infections. Phages of some fish pathogenic 
bacteria, such as Aeromonas salmonicida, A. hydrophila, Edwardsiella tarda, Lactococcus 







C.3. Phage therapy 
From the continued observations and experiences treating patients, d’Herelle quickly 
realized that not all phage preparations were effective and that care had to be taken both 
when preparing and when applying phages. At the same time, the advent of effective 
chemical antibiotics in the 1930s and 1940s led to the therapeutic use of phages in the West 
being curtailed. However, clinical use continued in the countries of the former Soviet bloc. 
Interest in phage therapy was reignited by increasing concern over antibiotic resistance 
and also by publication of successful results achieved by of Smith et al. (93, 94, 95), even 
demonstrating the apparently superior efficacy of phage therapy compared to antibiotics in 
a mouse model of E. coli infection (93). The advent of multi-drug resistant pathogens has 
forced the re-examination of phage therapy, with work being carried out to modern 
regulatory standards. 
A large amount of indicative data supporting the effectiveness of phage therapy is 
available from studies involving human patients in Eastern Europe, with few reported 
adverse events. This evidence for safety, while not up to current regulatory standards, is 
further supported by the exposure of humans to high levels of phages via everyday 
activities because of the ubiquitous nature of phages in the environment. 
Human safety trials have also been performed with increasing frequency including 
extensive safety trials undertaken on Staphage Lysate by Delmont Laboratories (USA) (98). 
This product, which contains high concentrations of antistaphylococcal phages, was 
administered to humans intranasally, topically, orally, subcutaneously, and intravenously. 
In over 12 years of use in humans, only minor side effects were observed (98, 99). In a 
formal safety study, Harold Brussow based at the Nestle Research Center, Switzerland, 




human volunteers (8). 
An FDA-approved phase I physician-led trial has been completed at a wound care 
center in Lubbock, Texas (87). Jusing a mixture of phages targeting Pseudomonas 
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Protective effects of the Aeromonas phages pAh1-C and 
pAh6-C against mass mortality of the cyprinid loach 




To investigate methods to control the mass mortality of cyprinid loaches (Misgurnus 
anguillicaudatus) caused by multiple-antibiotic-resistant Aeromonas hydrophila on a 
private fish farm in Korea, bacteriophages (phages), designated pAh1-C and pAh6-C, were 
isolated from the Han River in Seoul. The two isolated phages were morphologically 
classified as Myoviridae and showed similar infection patterns for A. hydrophila isolates. 
The two phages possessed approximately 55 kb (pAh1-C) and 58 kb (pAh6-C) of double-
stranded genomic DNA, and their gDNAs showed different restriction endonuclease 
digestion patterns. Both phages showed efficient bacteriolytic activity against fish-
pathogenic A. hydrophila from loaches. The latent periods of the phages were estimated to 
be approximately 30 min (pAh1-C) and 20 min (pAh6-C), while the burst sizes were 60 
PFU/cell (pAh1-C) and 10 PFU/cell (pAh6-C). The phages proved to be efficient in the 
inhibition of bacterial growth, as demonstrated by their in vitro bactericidal effects. 
Additionally, a single administration of either phage to cyprinid loaches resulted in 
noticeable protective effects, with increased survival rates against A. hydrophila infection. 




agents for the treatment of A. hydrophila infection in fish. 
 
Keywords: Cyprinid loach, Misgurnus anguillicaudatus; Multiple-antibiotic-resistant; 













The loach (Misgurnus spp.) is a member of the Cobitidae family (Lacepede, 1803) and 
inhabits freshwater systems throughout the world (17). Two species of loaches, the mud 
loach (M. mizolepis) and the cyprinid loach (Misgurnus anguillicaudatus), are cultured for 
a variety of uses, primarily for food, in Korea (16). The annual demand for loaches in 
Korea is one of the highest for fresh-water fish, due to their high nutritional value and use 
in both folk medicine and Buddhist ceremonies. 
Aeromonas spp. are primary organisms of normal aquatic microflora, and recently, there 
has been an increasing appreciation of their role as waterborne pathogens of fish and 
humans (31). Aeromonas hydrophila is a motile aeromonad that can cause disease in fish, 
resulting in high rates of mortality (2, 3, 8, 12, 15, 22). There has been an increasing 
incidence of antimicrobial resistance among Aeromonas sp. isolated from aquaculture 
environments (15, 33, 36, 37). Multiple-antibiotic-resistant A. hydrophila exists in 
aquaculture systems and contributes to the high rate of mortality within the fish industry in 
Korea (15). Although the majority of the loach population in Korea is cultured and A. 
hydrophila is one of the main causes of mass mortality in these fish, no effective method 
has been proposed for the control of A. hydrophila infection in aquaculture, except for the 
application of additional antibiotics. 
The use of phages has been proposed for the treatment of infectious disease, and several 
studies have shown that phages can be used successfully for the treatment of bacterial 
infections in both humans and animals (4, 6, 20, 21, 40). Phage therapy is advantageous in 
that it is natural and relatively inexpensive, and so far, no serious or irreversible side 




bacteria have been conducted (23, 24, 25, 26, 30, 34, 41), there have been few attempts to 
use phages to control bacterial infections in fish (29). This study aimed to isolate and 
characterize A. hydrophila-specific phages and to evaluate their therapeutic potential 
during experimental infections of loaches with A. hydrophila. 
 
1.2. Materials and methods 
1.2.1. Bacterial strains and culture media 
The bacterial strains (n = 17) used in this study included 5 A. hydrophila strains (3 fish-
pathogenic clinical isolates and 2 environmental isolates), 4 strains of other Aeromonas spp. 
(3 fish-pathogenic clinical isolates and 1 environmental isolate), and 8 additional strains of 
different genera; these strains are listed in Table 1.1. Laboratory stock strains (Table 1.1) 
were used to determine the host range of the isolated phages. Tryptic soy broth (TSB) and 
tryptic soy agar (TSA) were used for bacterial culture and phage PFU assays. 
 
1.2.2. Phage isolation and host range 
Phages were isolated from natural water of the Han River in May 2010 by the 
enrichment technique. A water sample (100 ml) was filtered through a 0.45 μm pore-size 
membrane filter, and the filtrate was mixed with 100 ml of TSB containing fish-pathogenic 
A. hydrophila (JUNAH) as the indicator organism. After 24 h of growth at 25 °C with 
gentle agitation, the culture was centrifuged (13,000 rpm/10 min) and filtered again. The 
phage activity in the supernatant was then detected with a spot assay (5). The phages were 
further purified by a CsCl continuous density gradient (35). 




of clarity: clear, turbid, and no reaction. A plaque-forming unit (PFU) assay was performed 
using the double-agar-layer method (30). The number of PFU was determined after 24 h of 
incubation at 25 °C, and the efficiency of plating (EOP) was also calculated. The host 
ranges of the two phages were determined by the double-agar-layer method. 
 
1.2.3. Electron microscopy 
Phage particles were negatively stained with 2% uranyl acetate, and electron 
micrographs were captured with a JEM 1010 transmission electron microscope (JEOL, 
Akishima, Japan) and a LIBRA 120 energy-filtering transmission electron microscope 
(Carl Zeiss, Germany). The phage size was considered to be the average of 5-7 
independent measurements. 
 
1.2.4. One-step growth 
One-step growth curves were obtained for pAh1-C and pAh6-C according to the 
method of Verma et al. (39). The optical density (OD) of mid-exponential host bacterial 
cultures (A. hydrophila JUNAH) at 600 nm was adjusted to a corresponding cell density of 
8.0×106 CFU/ml. The phage suspension (10 μl) was added to 10 ml of the bacterial culture 
to obtain a multiplicity of infection (MOI) of 0.001. The phages were allowed to adsorb for 
5 min at room temperature. The mixture was then centrifuged (13,000 rpm/3min), and the 
resulting pellet was resuspended in 20 ml of TSB. Samples (100 μl each) were collected at 







1.2.5. Phage DNA isolation and restriction endonuclease analysis 
Phage DNA was extracted from pure stocks as previously described (35) and subjected 
to nuclease treatment using DNase I, RNase A, and Mung bean nuclease according to the 
supplier’s instructions (Takara Bio Inc., Japan). In addition, the size estimation and 
restriction analysis of phage DNA were performed by pulsed-field gel electrophoresis, as 
described previously by Kim et al. (19). 
 
1.2.6. Phage structural protein analysis 
Phage structural proteins were analyzed by SDS-PAGE as previously described (19). 
After electrophoresis, the protein bands were visualized by staining the gel with Coomassie 
blue R-250 and identified by liquid chromatography-tandem mass spectrometry (LC-
MS/MS) at the National Instrumentation Center for Environmental Management (NICEM) 
at Seoul National University. 
 
1.2.7. Phage stability test 
Phage stability tests were conducted as described elsewhere (39), with some 
modifications. Briefly, to evaluate the stability of the phages in organic solvents, equal 
volumes of phage solution (105 PFU/ml) and appropriate organic solvents, such as 
chloroform, ethanol, and ether, were mixed and incubated at 25 °C for 1 h. To evaluate the 
stability of the phages at different pH values, the pH of the TSB was adjusted with either 1 
M HCl or 1 M NaOH to obtain solutions with pH values of 3, 5, 7, 9, and 11. The pAh1-C 
and pAh6-C phage suspensions were adjusted to obtain a final concentration of 107 
PFU/ml and were subsequently incubated at 25 °C for 1 h. Phage suspensions maintained 




30, 37, 50, and 65 °C) was determined by incubating the phages (105 PFU/ml) at the 
respective temperatures for 1 h. After incubation, the phage titer was estimated by the 
double-agar-layer method. 
 
1.2.8. Host cell lysis test 
The bactericidal effect of the phages on A. hydrophila (JUNAH) was determined by 
measuring the viable bacterial counts throughout the incubation period. TSB (20 ml) was 
inoculated with 0.1 ml of an overnight A. hydrophila (JUNAH) culture and incubated at 
25 °C with shaking until the early exponential phase was reached (OD600 nm = 0.1) (8.0×10
6 
CFU/ml). The phages were added at the indicated MOIs (multiplicity of infection), and the 
changes in OD were monitored for 24 h. 
 
1.2.9. Preparation of phage-resistant A. hydrophila variants 
An A. hydrophila (JUNAH) culture was treated with an undiluted suspension (1010 
PFU/ml) of the pAh1-C and pAh6-C phages. Colonies appearing on the plate after 2 days 
of incubation at 25 °C were purified on TSA, and the selection for phage-resistant variants 
was repeated. Finally, the cultures that produced no PFU after the addition of 1010 PFU/ml 
of each phage were used as phage-resistant variants. 
 
1.2.10. Phage treatment of infected fish 
A total of 2,400 healthy cyprinid loaches (Misgurnus anguillicaudatus) (average 
weight: 14.98 g) were divided into 60 groups in 7 L fiber plastic tanks at 25 ± 1 °C. In the 
1st experiment, all fish were infected intraperitoneally (IP) with A. hydrophila (JUNAH), 




concentrations of bacteria injected were 2.6×106 CFU/fish for the 1st trial and 2.6×107 
CFU/fish for the 2nd trial. The concentrations of phages used were 3.0×107 PFU/fish for 
pAh1-C and 1.7×107 PFU/fish for pAh6-C. In the 2nd experiment, all conditions were the 
same as in the 1st experiment, but the treatment groups were fed pellets (0.5% based on 
body weight) that had been impregnated with the phage suspensions containing pAh1-C 
and pAh6-C. 
Six groups of 40 loaches were used to study the virulence of the phage-resistant A. 
hydrophila (JUNAH) variants. The mortality rates of the fish were recorded daily for 7 
days, and the kidneys of both the dead and surviving fish were subjected to a bacterial 
isolation study, as previously described (15). Every experiment was performed on three 
separate occasions, and the results shown represent the mean of these three observations ± 
the standard deviation (SD). All animal experiments were performed according to the 




1.2.11. Statistical analysis 
The experimental results were analyzed for statistically significant differences using 
Student’s t-test. A P value of less than 0.05 was accepted as statistically significant. The 









1.3.1. Morphology, host range, and one-step growth patterns of the Aeromonas phages 
pAh1-C and pAh6-C 
From May 2009 to December 2010, 22 phages were isolated from water samples from 
the Han River in Seoul. From the isolated phages, two Aeromonas phages, designated 
pAh1-C and pAh6-C, produced clear plaques and were selected for further studies (Figure 
1.1). pAh1-C formed small plaques (average diameter: 1.6 mm) in A. hydrophila JUNAH, 
while pAh6-C formed large plaques (average diameter: 3.8 mm). Both phages had 
isometric heads, necks, and contractile tails, with tail fibers. Based on their morphologies 
and according to the classification system of Ackermann (1), both phages belong to the 
family Myoviridae (Figure 1.1). The tail lengths were 113 ± 6 nm for pAh1-C and 124 ± 6 
nm for pAh6-C (mean ± SD) (n = 10), while the widths were 14 ± 3 nm for pAh1-C and 18 
± 1 nm for pAh6-C (n = 10). The head diameters were 41 ± 3 nm for pAh1-C and 63 ± 3 
nm for pAh6-C (n = 10). 
To evaluate the host ranges of pAh1-C and pAh6-C, they were tested on various 
Aeromonas spp. and A. hydrophila strains. Among the 9 Aeromonas sp. tested, the two 
phages inhibited the growth of all A. hydrophila strains (n = 5), with pAh1-C producing 
clear plaques on two strains and pAh6-C producing clear plaques on three strains. The EOP 
values varied among the Aeromonas spp., and no strain showed a value higher than that of 
the indicator host strain JUNAH (Table 1.1). pAh1-C and pAh6-C failed to lyse any of the 
other 8 bacterial strains used in this study. Additionally, a one-step growth test showed that 
the latent periods were approximately 30 min (pAh1-C) and 20 min (pAh6-C) and that the 





1.3.2. Genomic and proteomic characteristics of the Aeromonas phages pAh1-C and pAh6-
C 
The DNA of both phages was completely digested by DNase I but not by RNase A or 
Mung bean nuclease; thus, both phages were presumed to be double-stranded DNA phages 
(data not shown). In addition, the DNA of pAh1-C was digested by MspI, NcoI, and 
HpaII, and its size was estimated to be approximately 55 kb based on the distinct 
fragments resulting from NcoI digestion. Likewise, the DNA of pAh6-C was digested by 
MspI, SmaI, NcoI, and HpaII, and its size was estimated to be approximately 58 kb based 
on the distinct fragments resulting from HpaII digestion (data not shown). 
To further characterize pAh1-C and pAh6-C, their structural protein compositions were 
analyzed by SDS-PAGE and LC-MS/MS. At least 11 (pAh1-C) and 19 (pAh6-C) distinct 
protein bands, with molecular masses ranging from 11 to 105 kDa, were separated. Six 
(pAh1-C) and eight (pAh6-C) major protein bands were then subjected to LC-MS/MS for 
peptide sequencing (Table 1.3). 
The results revealed differences between the structural protein compositions of the two 
phages. Although pAh6-C possessed similar structural proteins as other Aeromonas phages 
reported, such as the Aeromonas phages Aeh1, 25, and 31, the structural proteins of pAh1-
C were similar to those of phages from species other than Aeromonas (Table 1.3). 
 
1.3.3. Phage stability test 
Ethanol treatment resulted in a much greater loss of the activity of both phages 
compared to treatment with either chloroform or diethyl ether (Figure 1.3a). Both phages 




pAh6-C was found to be slightly more pH-sensitive than pAh1-C. The optimal stability of 
the phages was found at pH 7.0 (Figure 1.3b), and they were relatively heat stable over a 
period of 1 h at 20 ~ 25 °C. However, the following reductions in phage activity were 
observed for pAh1-C and pAh6-C, respectively: 8.5 ± 0.2% and 19.4 ± 0.6% at 30 °C, 78.7 
± 2.3% and 64.7 ± 0.3% at 37 °C, and 97.9 ± 0.1% and 95.3 ± 0.7% at 50 °C. Incubation at 
65 °C for 1 h resulted in the complete inactivation of both phages (Figure 1.3c). 
 
1.3.4. Host cell lysis test 
The bactericidal effects of pAh1-C and pAh6-C were tested on early-phase A. 
hydrophila JUNAH cultures (Figure 1.4). The OD600 values of the uninfected control 
culture continued to increase during the incubation period. In contrast, infection with 
pAh1-C or pAh6-C inhibited the bacterial growth at MOIs of 0.01, 1, and 100 until 24 h. 
However, the bactericidal activity of pAh1-C contrasted with that of pAh6-C. The bacterial 
growth of cultures infected with pAh1-C was inhibited until 12 h, regardless of MOI, and 
then increased due to the growth of phage-resistant A. hydrophila. In contrast, the 
bactericidal activity of pAh6-C varied depending on the MOI. Although the OD600 values 
of the cultures infected with pAh6-C increased after 6 h regardless of MOI, the bacterial 
growth was inhibited most effectively at an MOI of 1. In addition, the OD600 values of 
cultures infected with an MOI of 100 were higher than those of cultures infected with an 
MOI of 1, due to the growth of phage-resistant bacteria. 
 
1.3.5. Phage-resistant bacterial variants and pathogenicity in fish 
Variant R1, which emerged after exposure to pAh1-C, was also resistant to pAh6-C, 




Variant R1 (resistant to both pAh1-C and pAh6-C) and Variant R2 (resistant only to phage 
pAh6-C) were used in the pathogenicity tests. The pathogenicities of these variants and 
their parent A. hydrophila (JUNAH) strain in loaches are shown in Table 1.2. The phage-
sensitive parent A. hydrophila (JUNAH) caused 100% mortality in the loaches following 
intraperitoneal injection with 1.8×107 CFU/fish. All of the fish died within 24 h of 
injection, and hemorrhages were observed on their surfaces. The inoculated bacteria were 
isolated in pure cultures from the kidneys of the dead fish. In contrast, the variants that 
were resistant to pAh1-C and/or pAh6-C were not pathogenic at the same dose (107 
CFU/fish) or at a higher dose (108 CFU/fish). 
 
1.3.6. Protective effect of phage administration 
The protective effects of intraperitoneal injection and oral administration of the phages 
against experimental A. hydrophila (JUNAH) infection are shown in Figure 1.5. In the 
first experiment, the fish were challenged with two different doses of bacterial suspension 
and were administered two types of phages by IP injection. The fish in the control groups 
that were not treated with phages began to die at 1 day post-infection, and the cumulative 
mortalities over seven days were 39.17 ± 3.82% (1st trial, 2.6×106 CFU/fish) and 100% 
(2nd trial, 2.6×107 CFU/fish). In contrast, the fish treated with phages showed lower 
mortality rates; in the 1st trial, no mortality was observed in the groups treated with pAh1-
C or pAh6-C, and in the 2nd trial, the cumulative mortalities were 43.33 ± 2.89% (pAh1-
C) and 16.67 ± 3.82% (pAh6-C) (Figure 1.5a, b). 
In the second experiment, the fish were challenged with the bacterial suspension as in 
the first experiment but received phage-impregnated feed rather than an intraperitoneal 




2nd trial, 95.83 ± 3.82%) that were similar to those in the first experiment. However, the 
fish treated with phages showed lower mortality rates than those of the control group. In 
the 1st trial, the cumulative mortality rates were 17.50 ± 2.50% following treatment with 
pAh1-C and 11.67 ± 3.82% following treatment with pAh6-C. In the 2nd trial, the 
cumulative mortality rates were 46.67 ± 3.82% following treatment with pAh1-C and 
26.67 ± 2.89% following treatment with pAh6-C (Figure 1.5c, d). The administration of a 
high dose (1010 PFU/fish) of either phage to the experimental fish did not affect their 
physical condition or survival during a one-month period of observation. The bacteria were 
re-isolated from all of the dead fish except survived fish from the phage-administrated 
groups, indicating that the mortalities and protective effects were caused by A. hydrophila 
and the phages (pAh1-C and pAh6-C), respectively. In addition, bacteria isolated from the 
fish that had received the phage and died were still susceptible to both phages. 
 
1.4. Discussion 
In the current study, the indicator host strain JUNAH was determined to be the 
causative agent of the mass mortality of cyprinid loaches in a private fish hatchery in 
Korea (15). The JUNAH strain has demonstrated resistance to multiple antibiotics and was 
therefore able to cause the death of more than 50% of all fish reared on the farm despite 
the various antibiotic treatments administered. To discover an effective control agent 
against A. hydrophila infection in aquaculture, water samples were collected over a period 
of one year for phage isolation. 
An increasing incidence of antimicrobial resistance has become a threat to aquaculture 




liberal and possibly inappropriate use of antibiotics is a serious problem in aquaculture and 
causes therapeutic failures (9, 27). Alternatives to conventional antibiotics are urgently 
needed for the control of A. hydrophila in aquaculture. Although there have been some 
previous reports regarding the isolation of A. hydrophila phages (7, 23, 24, 25, 26), there is 
currently a paucity of studies reporting realistic assessments of their therapeutic 
applications. 
Previously, the therapeutic potential of phages in aquaculture environments was 
described (18, 28, 29). In the current study, two phages were isolated from water of the 
Han River in Seoul. Although both phages showed a similar host range, they formed 
differently shaped plaques and burst sizes, and their gDNAs showed different restriction 
endonuclease digestion patterns. In addition, the two phages exhibited different patterns of 
bactericidal activity. The method of experimental infection by IP injection was successfully 
performed in all experimental groups, in the same manner as previously reported (13, 32). 
The challenge trials using various methods such as bath immersion, cohabitation with 
infected fish, and oral administration of A. hydrophila-incorporated feed have not resulted 
in reduced mortality rates. The in vivo experiments evaluating the protective effects of the 
two phages indicated that pAh6-C controlled A. hydrophila infection more effectively than 
pAh1-C. Although the phage-resistant bacterial variants were not particularly pathogenic, 
the OD600 values of the pAh1-C-infected bacteria gradually increased after 12 h post-
infection. 
Wu et al. (41) isolated an A. hydrophila phage, AH1, and performed pathogenicity 
testing using loaches. However, these authors infected A. hydrophila with the phage 3 h 
before injection of the loaches, and this experiment was performed to indicate that the 




potential prophylactic use of the phage. Several A. hydrophila phages, such as Aeh1, Aeh2, 
PM1, PM2, PM3 and 18, have been reported (7, 23, 24, 25, 26). However, there have been 
no reports demonstrating the successful use of phages for the treatment of A. hydrophila 
infection or providing evidence of their potential as therapeutic agents. In the current study, 
the successful phage treatment of A. hydrophila infection emphasizes the potential of this 
therapeutic approach. In addition, pAh1-C and pAh6-C were able to inhibit A. hydrophila 
strains from various sources, including three fish-pathogenic isolates (SNUFPC-A6 from 
the sailfin molly Poecilia latipinna, SNUFPC-A8 from the cherry salmon Oncorhynchus 
masou masou, and JUNAH from the cyprinid loach) and two environmental isolates 
(SNUFPC-A20 from a river and SNUFPC-A21 from sewage); these results suggest the 
broad application of phages for the treatment of various fish species. Treatment of fish by 
IP injection resulted in noticeable protective effects, with increased survival rates observed 
for experimental fish compared to the controls. However, treating fish by IP injection in a 
fish culture environment is labor-intensive and time-consuming. Therefore, the protective 
effect of an oral method of administration was also evaluated for the purpose of identifying 
an effective and realistic route of administration on a larger scale, as required on a fish 
farm, and this treatment method also improved survival rates considerably. 
Despite the improvements in the survival of the phage-treated cyprinid loaches, a 
considerable degree of mortality remained. For the successful phage control of A. 
hydrophila infection, a combination of both isolated phages may help to increase the 
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Table 1.1. Bacterial strains used in this study and infectivity of phage pAh1-C and pAh6-C. 
 
Bacterial species (n) Strain 
Host rangea (EOPsb) 
Sourcec 
pAh1-C pAh6-C 
A. hydrophila (5) SNUFPC-A6 + (0.14 ± 0.02) ++ (0.64 ± 0.06) 1 
 SNUFPC-A8 + (0.34 ± 0.02) + (0.41 ± 0.08) 1 
 SNUFPC-A20 + (0.11 ± 0.08) + (0.15 ± 0.10) 1 
 SNUFPC-A21 ++ (0.87 ± 0.03) ++ (0.94 ± 0.02) 1 
 JUNAH ++ (1.00) ++ (1.00) 2 
A. media SNUFPC-A22 - - 1 
A. salmonicida ATCC 33658 - - 5 
A. sobria Aro - - 6 
A. veronii SNUFPC-A17 - - 1 
Streptococcus iniae ATCC 29178 - - 5 
S. agalactiae ATCC 27956 - - 5 
Enterococcus 
faecium 
CCARM 5192 - - 3 
E. faecalis CCARM 5168 - - 3 
Vibrio vulnificus ATCC 27562 - - 5 
V. parahaemolyticus ATCC 17802 - - 5 
V. alginolyticus ATCC 17749 - - 5 
Escherichia coli DH10B - - 4 
a  ++, clear plaque; +, turbid plaque; -, no plaque. 
b  The EOP (efficiency of plating) values were shown as the mean of observations at three different 
occasions. 
c  1, Han et al. (11); 2, Jun et al. (15); 3, obtained from the Culture Collection of Antimicrobial 
Resistant Microbes in Korea; 4, purchased from Invitrogen; 5, purchased from the American 








Table 1.2. Pathogenicities of phage-sensitive parent cells and phage-resistant variants of  A. 







No. of dead/total fish Mortality (%) 
Parent A. hydrophila 
(JUNAH) 
1st 1.8×106 14/40, 16/40, 15/40 37.50 ± 2.50 
2nd 1.8×107 40/40, 40/40, 40/40 100 ± 0 
     
Variant R1 1st 1.4×107 0/40, 0/40, 0/40 0 
 2nd 1.4×108 0/40, 0/40, 0/40 0 
 3rd 1.4×109 6/40, 8/40, 6/40 16.67 ± 2.89 
     
Variant R2 1st 1.0×107 0/40, 0/40, 0/40 0 
 2nd 1.0×108 0/40, 0/40, 0/40 0 
 3rd 1.0×109 4/40, 6/40, 5/40 12.50 ± 2.50 
a  Fish were intraperitoneal (IP)-injected with bacteria and were cultivated at 25 ± 1 °C and 
observed for 7 days. Variant R1 was resistant to both pAh1-C and pAh6-C; variant R2 was 











Protein name [Species] Sequence coverage Accession number 
(kDa) 
105 
e.6 conserved hypothetical protein 
[Enterobacteria phage T4] 
14.7% NP049742 
62 
hypothetical protein A2p47 
[Lactobacillus phage A2] 
13.7% NP680526 
49 
hypothetical protein EFP gp220 





















Protein name [Species] Sequence coverage Accession number 
(kDa) 
105 
NrdA-A aerobic NDP reductase large subunit 
[Aeromonas phage Aeh1] 
56.2% NP943927 
95 
gp7 base plate wedge initiator 
[Aeromonas phage Aeh1] 
53.9% NP944089 
61 
hypothetical protein Aeh1p299 
[Aeromonas phage Aeh1] 
49.9% NP944177 
51 
hypothetical protein Aeh1p026 
[Aeromonas phage Aeh1] 
49.2% NP943904 
44 
gp6 base plate wedge component 
[Aeromonas phage 25] 
44.8% YP656367 
36 
base plate tail tube cap 




[Aeromonas phage 31] 
58.6% YP238885 
17 
gp61.1 conserved hypothetical protein 






























Figure 1.1. Phage plaques formed in double layer agar plates with the indicator host strain, A. 
hydrophila JUNAH, and electron micrographs of two phages: (a) pAh1-C (bar = 100 nm) and (b) 
































Figure 1.3. Stability of pAh1-C (left) and pAh6-C (right) in the presence of various organic solvents 
(a), pHs (b), and temperatures (c). To test the stability of these phages in response to the different 
factors, optimal conditions such as sterile PBS (a), pH 7 (b), and 4 °C (c) were used as controls. All 
values represent the mean of three experiments performed in triplicate on separated occasions, with 









Figure 1.4. Bactericidal effects of pAh1-C (a) and pAh6-C (b) against A. hydrophila JUNAH. Early 
exponential-phase cultures of A. hydrophila JUNAH were co-cultured with pAh1-C (a) and pAh6-C 



















Figure 1.5. Cumulative mortality of different treatment groups following challenge with A. 
hydrophila via IP injection. (a) and (b) were treated by IP injection; (c) and (d) were treated by oral 
administration of phage-coated feed. control: injected with A. hydrophila (1st, 2.6×106 CFU/fish; 
2nd, 2.6×107 CFU/fish) but not treated; pAh1-C: treated with pAh1-C following A. hydrophila 
injection; pAh6-C: treated with pAh6-C following A. hydrophila injection. All results are shown as 









Bacteriophage Therapy of a Vibrio parahaemolyticus 
Infection Caused by a Multiple Antibiotic Resistant O3:K6 
Pandemic Clinical Strain 
 
Abstract 
Recently isolated Vibrio parahaemolyticus strains have displayed multiple antibiotic 
resistance. Alternatives to conventional antibiotics are needed, especially for the multiple-
antibiotic-resistant V. parahaemolyticus pandemic strain. A bacteriophage, designated 
pVp-1, that was lytic for V. parahaemolyticus was isolated from the coast of the Yellow 
Sea in Korea. The phage showed effective infectivity for multiple-antibiotic-resistant V. 
parahaemolyticus and V. vulnificus, including V. parahaemolyticus pandemic strains. The 
therapeutic potential of the phage was studied in a mouse model of experimental infection 
using a multiple-antibiotic-resistant V. parahaemolyticus pandemic strain. Phage-treated 
mice displayed protection from a V. parahaemolyticus infection and survived lethal oral 
and intraperitoneal bacterial challenges. This is the first report, to the best of knowledge, of 
phage therapy in a mouse model against a multiple-antibiotic-resistant V. 
parahaemolyticus pandemic strain infection. 
 







Vibrio parahaemolyticus, a gram-negative marine bacterium, is one of the most 
important causes of gastroenteritis associated with consumption of raw oysters (7). V. 
parahaemolyticus pandemic strains, such as O3:K6, are responsible for the current 
pandemics in many countries (14). Emergence of Vibrio species that are resistant to 
multiple antibiotics has been recognized as a serious global clinical problem (17). Recently 
isolated V. parahaemolyticus pandemic strains have displayed multiple antibiotic resistance, 
increasing concerns about possible treatment failure (11). 
Theoretically, bacteriophages (phages) can be used to treat infectious diseases both in 
humans and animals (2, 4, 5, 13, 20, 24). Phages display an effective bacteriolytic activity 
and possess several advantages over other antimicrobial agents, and no serious side effects 
of phage therapy have been described thus far (8, 20). Because all isolated V. 
parahaemolyticus strains have exhibited resistance to a broad variety of commercial 
antibiotics, it has been previously noted that alternatives to conventional antibiotics are 
needed (11). 
In this study, one lytic Siphoviridae phage, designated as pVp-1 (12) and infects V. 
parahaemolyticus pandemic strains, was isolated and characterized. It was aimed to 
determine whether this phage could be suitable for therapeutic use in a mouse model of a 







2.2. Materials and methods 
2.2.1. Bacterial strains 
V. parahaemolyticus ATCC 33844 was used as the host bacterial strain for phage 
isolation and amplification. CRS 09-17 (isolated from a patient with diarrhea; V. 
parahaemolyticus new O3:K6 pandemic strain) (11) was used to evaluate its therapeutic 
potential. 
 
2.2.2. Electron microscope examination 
Phage particles were negatively stained with 2% uranyl acetate, and electron 
micrographs were taken using a Zeiss TEM EM902. 
 
2.2.3. One-step growth 
The one-step growth curve of pVp-1 was determined according to the method of Verma 
et al. (23). Ten microliters of phage suspension was added to 10 ml of the mid-exponential 
host bacterial culture (ATCC 33844, 8.0×106 CFU/ml). The mixture was then centrifuged 
and the pellet was resuspended in 20 ml of TSB. Samples (100 μl) were taken at 5 min 
intervals and subjected to phage titration. 
 
2.2.4. Phage stability 
Phage stability tests were conducted as described elsewhere (23), with modifications. 
Briefly, phage stability to various conditions such as organic solvents (chloroform, ethanol, 
and ether; 25% of total volume), pH (3, 5, 7, 9, and 11), temperature (20, 25, 30, 37, 50, 




evaluated after 1 h incubation at 25°C (except for the temperature test). After incubation, 
the phage titer was estimated by the double-agar-layer method. 
 
2.2.5. Host cell lysis 
The bacteriolytic effect of the phage on V. parahaemolyticus CRS 09-17 was observed 
by determining viable bacteria counts throughout the incubation period. The phage was 
added to the early exponential phase (OD600nm = 0.1; 8.0×10
6 CFU/ml) of CRS 09-17 at the 
indicated multiplicity of infection (MOI), and the change in optical density (OD) was 
monitored for 24 h. 
 
2.2.6. Ethics statement 
Specific pathogen-free BALB/c female mice (8-weeks-old) were used with the approval 
of the Institutional Animal Care and Use Committee, Seoul National University, Seoul, 
Republic of Korea (Reg. No. SNU-120602-1). All animal care and experimental protocols 
were performed according to the guidelines of the Animal Ethical Committee, Seoul 
National University. 
 
2.2.7. Induction of V. parahaemolyticus infection in mice 
To determine the 50% lethal dose (LD50), V. parahaemolyticus CRS 09-17 was diluted 
with PBS to a range of 2.0×106 to 2.0×108 CFU per mouse in 200 μl and was administered 
by either the intraperitoneal (IP) or orogastric route (orally). Five mice were used for each 
concentration. The survival rate of mice was recorded until 7 days post-infection. Mice 
inoculated with CRS 09-17 were observed for their state of infection based on several 




experiment was replicated three times. 
 
2.2.8. Kinetics of phage in mice 
A phage in vivo kinetic assessment was performed as previously described (23), with 
several modifications. First, between the two groups, with each group composed of 21 
mice, one group was given an IP injection, while the other group was orally given the 
phage preparation (2.0×108 PFU/mouse). Second, the two groups (seven mice per group) 
were given an IP injection or was oral administered a heat-inactivated (65°C, 2 h) phage 
suspension as the negative control. Finally, at appropriate time intervals, four mice (three 
test mice and one control mouse) from the IP and oral groups were euthanized, and phage 
titers were determined from their organs. 
 
2.2.9. Treatment of bacteremic mice with phage pVp-1 
The efficacy of phage therapy was evaluated in two separate experiments using the V. 
parahaemolyticus CRS 09-17 infection mouse model. In the first experiment, two groups 
of mice (control/treatment; five mice in each group) were challenged by an IP injection of 
a LD50 of CRS 09-17. Each mouse was treated with a single IP injection of phage pVp-1 
(2.0×108 PFU per mouse) or PBS, 1 h after the bacterial challenge (2.0×107 CFU per 
mouse).  
In the second experiment, all conditions were similar to those of the first study except 
that the bacterial challenge (2.0×107 CFU per mouse) and phage treatment (2.0×108 PFU 
per mouse) were administered orally. Both experiments were repeated five times, and the 
health condition of the mice was monitored for 72 h.  




bacteria and received only phage (2.0×1011 PFU per mouse) by IP and oral routes, as 
described previously (22). The state of health of these mice was monitored for 28 days. 
 
2.2.10. Quantitative analysis of V. parahaemolyticus / phage in mouse organs 
During the phage treatment experiment described above, three mice from each group 
were euthanized at 0, 1, 3, 6, 12, 24, 36, 48, and 72 h post-treatment. As the main target 
organs of gastroenteritis, the stomach and intestine were removed and homogenized to 
quantify viable bacteria and phage. Bacterial and phage counts were normalized by organ 
weight when the organs were halved and processed for histopathological examination. A 
selective medium (CHROMagarTM Vibrio containing resistant antibiotics) was used for the 
enumeration of V. parahaemolyticus, as described previously (11). This experiment was 
repeated three times. 
 
2.2.11. Histopathology of organs 
A portion (one-half) of the stomach and intestine was fixed and cut by a standardized 
method and placed in tissue cassettes for further processing. Slides of hematoxyline-eosin 
stained tissues were prepared and observed for histopathology by microscopic examination. 
Histopathology was examined for severity in a blinded manner. 
 
 
2.2.12. Measuring phage immune response 
Mice were immunized using an IP injection of phage (2.0×1010 PFU per mouse) at 
intervals of 0, 4, 6, and 8 weeks, as described previously (22). At various times, the sera 




performed as previously described (9). Immunoglobulins were detected with goat anti-
mouse Ig (immunoglobulin) M- or IgG-specific antibodies. 
 
2.2.13. Statistical analyses 
Statistically significant differences in all of the experiments were determined using 
Student’s t-test. The SPSS statistical software package version 16.0 (SPSS, Chicago, IL) 
was used for all statistical analyses. 
 
2.3. Results 
2.3.1. Characterization of Vibrio phage pVp-1 
The Vibrio phage pVp-1 formed small plaques (average diameter, 1 mm) in a lawn of V. 
parahaemolyticus ATCC 33844. Based on its morphology, the phage was assigned to the 
family Siphoviridae, according to the classification system of Ackermann (1) (Figure 2.1). 
Additionally, one-step growth of pVp-1 showed that it had a latent period of approximately 
15 min with a burst size of 47 PFU/cell (Figure 2.2). 
The pVp-1 was sensitive to organic solvents. After 1 h of incubation in chloroform, 
diethylether, and ethanol, phage activity decreased to 37.7%, 33%, and 56.6%, respectively. 
However, no effect on phage activity was observed within a pH range of 5-11, and the 
activity remained at a high level (94.9%) at pH 3. In addition, the phage was relatively heat 
stable over a temperature range of 20-37°C, and no loss in activity was observed, although 
phage activity decreased to 3.3% at 50°C and 0% at 65°C. Upon exposure to UV light, a 





2.3.2. Phage therapeutic application on pandemic clinical strain 
The bacteriolytic effect of pVp-1 was tested on an early exponential phase culture of V. 
parahaemolyticus CRS 09-17 (Figure 2.3). When the culture was not infected by pVp-1 
(control), the OD600 value continued to increase throughout the incubation. In contrast, 
bacterial growth induced by pVp-1 was apparently retarded at an MOI of 0.1, 1, and 10 
until 24 h. Bacterial growth was properly inhibited at an MOI 1 and 10, whereas the OD600 
value at an MOI of 0.1 increased gradually and reached 1.0 after 9 h. 
In animal experiments, invalidism and the wellness of the animals were measured using 
four criteria: physical condition, survival rate, CFU per gram of target organs (stomach/ 
intestine), and histopathology of target organs (stomach/intestine). The LD50 of V. 
parahaemolyticus CRS 09-17 was examined using IP and oral routes of administration. 
The LD50 of the IP and oral routes were between 2.0×10
6 and 2.0×107 CFU per mouse 
(Figure 2.4). The IP and oral mouse infection model was an acute death model; all 
mortality occurred within 36 h. After 36 h post-infection, mice that survived entered the 
recovery stage. 
To examine in vivo kinetics, a pVp-1 kinetic analysis was performed in mice treated by 
IP and oral administration (Figure 2.5). In the IP group, a titer of 7.9×105 PFU/ml in blood 
during the first hour increased to a titer of 6.4×106 PFU/ml over the next 6 h. However, by 
12 h of inoculation, the titer decreased to 2.1×105 PFU/ml. Likewise, pVp-1 titers in the 
stomach and intestine were also estimated. In the stomach, a titer of 1.3×104 PFU/g at 1 h 
increased to a titer of 3.4×105 PFU/g at 6 h and decreased to 4.5×103 PFU/g at 12 h. 
However, in the intestine, a titer of 9.2×104 PFU/g at 1 h increased to a titer of 6.1×106 
PFU/g at 12 h and decreased to 4.8×104 PFU/g at 24 h. 




titer of 3.8×106 PFU/ml at 12 h and decreased to 6.7×105 PFU/ml at 24 h. In the stomach, a 
titer of 1.1×103 PFU/g at 1 h increased to a titer of 1.2×105 PFU/g at 3 h and decreased to 
1.1×104 PFU/g at 6 h. In the intestine, a titer of 2.9×105 PFU/g at 1 h increased to a titer of 
5.4×105 PFU/g at 3 h and decreased to 3.4×105 PFU/g at 6 h. There was a gradual fall in 
the titer thereafter and after 48 h of inoculation, pVp-1 became undetectable. During the 
experiment, all mice were healthy and in normal condition. 
To determine whether phage pVp-1 could treat a CRS 09-17 infection, pVp-1 was 
administered by IP and oral routes 1 h after a CRS 09-17 challenge (Figure 2.6). After 6 h 
of infection, all control (infected but not phage-treated) mice were visibly ill, lethargic, and 
scruffy. The control group fatality rate was 56% (IP) and 52% (oral) within 36 h. The 
stomachs and intestines of control mice contained high levels of bacteria (stomach, 1.0×104 
CFU/g; intestine, 5.3×103 CFU/g) until 12 h post-infection (Figure 2.6). In contrast, phage 
treatment resulted in excellent protection in terms of all four criteria. The phage-treated 
mice appeared to be only slightly ill and were protected up to 92% (IP) and 84% (oral) 
from the lethal infection induced by CRS 09-17 (2.0×107 CFU) after the administration of 
a single dose of purified pVp-1 of 2.0×108 PFU (Figure 2.6). The stomach/intestine CFU 
and histopathologic features were improved by phage treatment. In the IP treatment group, 
a decrease in stomach/intestine CFU was obtained with the increased phage titer at 12 h 
post-infection, 1.7×102/3.7×102 CFU/g and 5.7×103/2.3×104 PFU/g (Figure 2.6). In the 
oral treatment group, the maximum CFU and PFU values of the stomach/intestine were 
observed at experimental onset, and the values gradually decreased (Figure 2.7). In 
addition, the histopathologic features demonstrated that the V. parahaemolyticus infection 
significantly damaged the intestinal tract in as observed by the H&E stain (Figure 2.8C-D) 




structure of the colon was accompanied by a thinning of the wall, enterohemorrhage, and 
loss of crypts in the mucosal layer (Figure 2.8C-D). However, treatment with phage 
ameliorated the histological damage in the colon. The histopathological examination of the 
colon of the phage-treated mice revealed a significant recovery in the destruction of the 
intestinal wall and crypts, hemorrhages and inflammation after both IP and oral treatment 
(Figure 2.8E-F). This suggests that phage-treated animals showed strongly reduced 
infection severity and could survive a lethal bacterial challenge. In addition, the 
administration of a high dose (2.0×1011 PFU/mouse) of pVp-1 alone did not affect the 
physical condition or survival during 28 days of observation. 
 
2.3.3. Immune response to phage pVp-1 
After the fourth phage induction in a series of phage injections in mice, titers of IgG 
and IgM against the phage increased above background levels by 170-fold and 50-fold 
respectively (Figure 2.10). No anaphylactic reactions, changes in physical condition or 
adverse events were observed during the course of these multiple injections of phage. 
 
2.4. Discussion 
Based on the morphological analysis, pVp-1 was classified into the family Siphoviridae, 
and it demonstrated a broad host range. This differs from a prior finding that Siphoviridae 
phages are generally considered to have restricted host ranges (26). The phage infected 
74% (20 / 27) of all multiple antibiotic resistant V. parahaemolyticus strains used in this 
study, including the two pandemic strains CRS 09-17 and CRS 09-72. Interestingly, pVp-1 




which represents a multiple-antibiotic-resistant new O3:K6 pandemic strain (tdh+, ORF8+, 
toxRS/new+) (11). The results obtained from pVp-1 showed its lytic nature with a latent 
period and a large burst size. Full genome sequencing of pVp-1 was identified no 
similarity match with lysogenic or phage integrase-related genes (considered as markers of 
temperate phages), indicating that it is a novel, newly isolated lytic phage (12). This result 
emphasizes the potential of pVp-1 as a therapeutic agent, as described previously by 
Gutiérrez et al. (8), who regarded lytic phages as more suitable phages for therapy. 
Furthermore, the stability of pVp-1 over a wide range of pH (3-11) and temperature (20-
37°C) clearly indicates that pVp-1 would be highly stable in the body. 
Current analyses show that the search for new antibiotics conducted by pharmaceutical 
companies is becoming more and more restricted due to the growing costs of conducting 
the appropriate trials, low profits, and high risk of the investment, precisely because of the 
possibility of a rapid acquisition of resistance to the new drug (6, 16, 21, 25). It was 
hypothesized that phage therapy can be useful, especially in epidemics caused by multiple-
antibiotic-resistant pandemic strains. To evaluate the therapeutic potential of pVp-1, a 
mouse model of V. parahaemolyticus CRS 09-17 was used. In the cell lysis test of pVp-1, 
the growth of CRS 09-17 was apparently inhibited after pVp-1 inoculations at MOIs of 1 
and 10, although pVp-1 partially inhibited the bacterial growth at an MOI of 0.1. 
Because the route of phage inoculation is important, in vivo phage kinetics were 
ascertained following an IP and oral administration of pVp-1. To apply pVp-1 at an MOI of 
10 (CRS 09-17, 2.0×107 CFU per mouse), where the maximum effect of cell lysis was 
examined, kinetic tests were performed with pVp-1 at 2.0×108 PFU per mouse. Phage titers 
in the stomach as well as the intestine indicated that pVp-1 was maintained at higher 




These findings suggest that pVp-1 might be efficacious for prophylactic approach. In blood, 
pVp-1 reached a high titer within the first hour following IP injection. In contrast, no phage 
was detected until 1 h, and it took longer to reach a higher titer, when it was administered 
orally. Moreover, the highest titer in each organ was also much higher in the IP route of 
administration compared to the oral route of administration. Therefore, it was speculated 
that the IP route of administration would be the more suitable route of administration. 
Phage treatment trials in the mouse model for CRS 09-17 demonstrated that the 
application of pVp-1 can protect from a V. parahaemolyticus infection in all four criteria, 
and pVp-1 can be used as a therapeutic agent to reduce the impact of epidemics caused by 
multiple-antibiotic-resistant pandemic strains. 
While pVp-1 invoked an immune response in mice, the antibodies raised over the 
course of repeated injections were not associated with anaphylaxis or other adverse 
reactions. These experiments were designed as a model for acute human infections, where 
antibiotics are no longer effective and a single course of phage treatment may rescue the 
patient. If phages are to be employed repeatedly (e.g., for chronic infections), selection use 
and phage display may produce phage variants that are less prone to induce an immune 
response (2). 
In 2006, the Food and Drug Administration (FDA) approved the use of a commercial 
phage cocktail (List-Shield; Intralytix, Inc.) as a biocontrol agent. This is confirmation that 
the FDA’s view of phages is that they are safe for human use and opens the doors for phage 
commercialization for human applications (10). Despite no reports of significant adverse 
reactions during the long history of phage administration in humans, phage therapy still 
needs to gain credibility to overcome the regulatory hurdles facing its adoption in 




preparation methodologies such as the purification and removal of endotoxins for safety in 
phage therapy to prevent anaphylactic responses (3, 15, 18, 19). 
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Figure 2.3. The bacteriolytic effect of pVp-1 against V. parahaemolyticus CRS 09-17. Early 
exponential phase cultures of V. parahaemolyticus CRS 09-17 were co-cultured with pVp-1 at MOIs 





















Figure 2.4. Experimental infection of mouse model. Experimental infection by IP, A or orally, B. 
Four test groups were infected (dose volume 0.2 ml) with 2.0×108 CFU per mouse (◆), 2.0×107 
CFU per mouse (◇), 2.0×106 CFU per mouse (▲), and 2.0×105 CFU per mouse (△) of V. 








Figure 2.5. Kinetics of pVp-1 in the mouse model. Phage was injected via IP, A and administered orally, B at 108 PFU/mouse. After 1, 3, 6, 12, 24, 
36, and 48 h of phage inoculations, blood, stomach, and intestine were removed and their phage titers were estimated. Titers are presented as the 








Figure 2.6. Effect of phage treatment on V. parahaemolyticus infection in mice. A, The survival rate 
of mice in the control (treated with phosphate buffered saline, PBS) and treated (phage treated) 
groups. The LD50 of V. parahaemolyticus CRS 09-17 (2.0×10
7 CFU/mouse) that was required to 




PFU/mouse), was applied by IP injection and oral administration after a 1 h CRS 09-17 challenge 
because the maximum effect of cell lysis was examined at an MOI of 10. B, CFU per gram of target 
organs (stomach/intestine) in the experimental mice through IP infection / IP treatment. C, The PFU 
per gram of target organs (stomach/intestine) in the experimental mice through IP infection/ IP 
treatment. The bars show the mean, and the error bars show the standard error. Significant 

























Figure 2.7. CFU and PFU values of the stomach/intestine. Effect of phage treatment on V. 
parahaemolyticus infection in mice. A, CFU per gram of target organs (stomach/intestine) in the 
experimental mice through oral infection / oral treatment. B, The PFU per gram of target organs 
(stomach/intestine) in the experimental mice through oral infection/ oral treatment. In the oral 
infection / oral treatment group, the maximum CFU and PFU values of stomach / intestine were 
determined at the experimental onset and the values were gradually decreased. The bars show the 










Figure 2.8. Histopathologic features of the intestines of mice infected with V. parahaemolyticus 
CRS 09-17 and treated with the phage pVp-1. The micrographs depict the histologic features of the 
mice from the experiment. A, A healthy mouse that only received a PBS IP injection. B, A healthy 
mouse that only received PBS oral administration. C, A control mouse (IP infection / no phage 
treatment). D, A control mouse (oral infection / no phage treatment). Deteriorated crypts are 
indicated in C and D. E, A phage-treated mouse (IP infection / IP treatment). F, A phage-treated 
mouse (oral infection / oral treatment). The phage-treated mice demonstrated the protected 
morphology of the crypt in both the IP and oral treatment groups. Sections were stained with 









Figure 2.9. The sensitivity of pVp-1 to various organic solvents: A, pH: B, temperatures: C, and 
exposure to UV light: D. For sensitivity to various factors, optimal conditions included sterile PBS: 
A, pH 7: B, 4°C: C, and 0 min: D and acted as a control. All values represent the mean of three 
experiments performed in triplicate on different occasions, with error bars representing the standard 













Figure 2.10. Antibody titers in mice (n = 5) to repeated injections of phage pVp-1. Phage was IP 
injected at the indicated time points. The resulting titers of anti-IgG and anti-IgM antibodies are 


















Complete genome sequence of a novel marine siphovirus 
pVp-1, infecting Vibrio parahaemolyticus 
 
Abstract 
Among the abundant bacteriophages that belong to the order Caudovirales in the ocean, 
the genome sequence of marine siphoviruses are poorly investigated in comparison to 
myo- or podoviruses. Herein, the complete genome sequence of Vibrio phage pVP-1 was 
reported, which belongs to the family Siphoviridae and infects V. parahaemolyticus ATCC 
33844. 
 
















Marine viruses are the most abundant biological entities in the ocean (10), thus making 
its genome analysis essential for a better understanding of its enormous genetic diversity 
(1). Most reported marine viruses up to date are bacteriophages (phages) that belong to the 
order Caudovirales, which is divided into three families: Myoviridae, Podoviridae and 
Siphoviridae (10). Among the genome-sequenced marine phages, siphoviruses are 
relatively poorly investigated (9) and only two of those including phiHSIC (7) and SIO-2 
(1) were studied and reported to infect Vibrio spp.. Herein, the complete genome sequence 
of a novel marine siphovirus pVp-1 was reported, which was isolated from the coastal 
water of the Yellow sea in Korea and infects V. parahaemolyticus ATCC 33844, which was 
isolated from patient with food poisoning. 
 
 
3.2. Materials and methods 
Genomic DNA was extracted as previously described (8), and sequenced using standard 
shotgun sequencing reagents and a 454 GS-FLX Titanium Sequencing System (Roche) by 
Macrogen in Korea (Approximately 50 × coverage). The full-length genome sequence was 
obtained by sequence assembly using the SeqMan II sequence analysis software 
(DNASTAR). The putative open reading frames (ORFs) were predicted using Glimmer 
3.02 (2) and GeneMark.hmm (6), and putative ORF functions were analyzed by BLASTP 
and InterProScan (12). Putative tRNA genes were searched for using tRNAscan-SE (v. 






The double-stranded and non-redundant DNA genome of pVp-1 was 111,506 bp in 
length with a G+C composition of 39.71%. A total of 157 ORFs containing more than 40 
amino acid residues and 19 tRNAs (including 1 pseudogene) were identified, suggesting 
this as the first marine phage genome in the family Siphoviridae with a large number of 
tRNAs capable of infecting V. parahaemolyticus. A number of 48 ORFs showed no 
homology to proteins from the GenBank database, while other 69 and 40 ORFs code for 
proteins with some homology to known phage and bacteria-related proteins, respectively. 
Among the 40 bacteria-related genes in phage pVp-1, 5 ORFs (orf34, orf38, orf79, orf85 
and orf97) were highly homologous to Vibrio-related proteins and 35 ORFs shared some 
similarities with unrelated bacteria spanning a wide range of phyla. The positions, 
directions, sizes, molecular weights, and putative functions of each pVp-1 ORFs are shown 
in Table 3.1. The results demonstrate that pVp-1 has a unique genomic composition. 
Lysogeny genes responsible for the lysogenic properties of this phage, such as integrase, 
were not found in the genome of pVp-1. None of the ORFs showed any similarities with 
pathogenecity factors that can cause problems in clinical usage. 
Bioinformatic analyses were performed for the assignment of putative functions to 69 
phage-related ORFs, and those ORFs were clustered together by at least 3 functional roles 
such as DNA metabolism (orf2, orf3, orf4, orf6, orf7, orf12, orf14, orf15, orf16, orf17, 
orf18, orf21, orf28, orf32, orf42 and orf52), viral morphogenesis (orf139, orf141, orf143, 
orf144, orf148, orf149, orf153, orf155, orf156 and orf157) and lytic properties (orf73, 
orf82 and orf83). Interestingly, most ORFs encoding DNA metabolism and viral 




functional roles, and were similar (≤ 79%) to those of T5 (11) or T5-like phages (3, 4), thus 
indicating a close genetic relatedness between pVp-1 and those phages. Genomic 
comparison of pVp-1 with the phage T5 revealed that these two phages are highly similar 
in gene inventory. The putative ORFs in the pVp-1 genome were predicted using 
CoreGenes and had high similarity to the ORFs of the phage T5 (Figure 3.1). Additionally, 
according to the ACT comparison results, two parts of the pVp-1 genome was reversed 
relative to the order in the T5 genome (Figure 3.2). 
In contrast, there were no sequence similarities to marine Vibrio phages belonging to 
Siphoviridae (phiHSIC and SIO-2), and high proportions of genes in pVp-1 were not 
similar to other sequenced phages or bacteria. 
The genome sequence of Vibrio phage pVp-1 was deposited in the GenBank under 




Based on these results, the newly sequenced Vibrio phage pVp-1 could be considered as 
a novel T5-like virus, and will help to advance the understanding of the biodiversity of 
marine phages belongs to the family Siphoviridae. In addition, a novel virulent phage, pSf-
1, capable of inhibiting V. parahaemolyticus growth indicated the safety needed for phage 
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Table 3.1. Predicted genes and gene products of pVp-1. 
Gene Gene product 
Amino acid 
Identity (%) 
Putative function [organism] (E-value) 
Predicted TMH 









1 109-663 + 185 21.1 10.11 31 
gp30 DNA ligase 
[Acinetobacter phage Acj61] (9.7) 
0 N 
2 690-1142 - 151 17.0 5.14 47 
putative deoxyUTP pyrophosphatase 
[Enterobacteria phage T5] (4e-26) 
0 N 
3 1142-2014 - 291 33.8 4.77 52 
flap endonuclease 
[Enterobacteria phage T5] (2e-71) 
0 N 
4 2011-2499 - 163 18.7 8.56 53 
D14 protein 
[Enterobacteria phage T5] (1e-44) 
0 N 
5 2492-2785 - 98 11.0 5.72 37 
response regulator receiver domain protein 
[Bacteroides ovatus SD CC 2a] (3.5) 
0 N 
6 2778-4652 - 625 71.4 5.72 43 
probable exonuclease subunit 2 
[Enterobacteria phage T5] (5e-117) 
0 N 
7 4642-5625 - 328 37.9 5.65 56 
putative recombination endonuclease, subunit D12 
[Enterobacteria phage T5] (2e-93) 
0 N 
8 5625-6002 - 126 14.9 4.52 34 
ATP-dependent DNA helicase RecG 
[Fusobacterium periodonticum ATCC 33693] (3.0) 
0 N 
9 6049-6852 - 268 29.9 4.74 31 
D11 protein 
[Enterobacteria phage T5] (8e-28) 
0 N 
10 6849-7052 - 68 8.2 6.55 55 
hypothetical protein T5.125 
[Enterobacteria phage T5] (8e-12) 
0 N 
11 7269 - 7667 - 133 15.3 4.58 27 
periplasmic sensor signal transduction histidine 
kinase 
[Ruegeria sp. R11] (1.0) 
0 N 
12 7700 - 9055 - 452 51.2 8.34 55 
putative ATP-dependent helicase 
[Enterobacteria phage T5] (2e-136) 
0 N 
13 9052 - 9567 - 172 20.5 9.62 38 
hypothetical protein 





14 9557 - 12130 - 858 97.8 5.75 58 
DNA polymerase 
[Enterobacteria phage T5] (0.0) 
0 N 
15 12228 - 12983 - 252 29.1 6.39 43 
DNA primase 
[Enterobacteria phage T5] (3e-51) 
0 N 
16 13087 - 14487 - 467 52.5 5.04 39 
putative replicative DNA helicase 
[Enterobacteria phage T5] (7e-97) 
0 N 
17 14548 - 15312 - 255 27.7 6.05 50 
D5 protein 
[Enterobacteria phage T5] (4e-52) 
0 N 
18 15317 - 16093 - 259 28.0 8.72 52 
NAD-dependent DNA ligase, subunit B 
[Enterobacteria phage T5] (8e-57) 
0 N 
19 16250 - 16777 - 176 19.8 5.26 32 
hypothetical protein 
[Pseudomonas phage KPP10] (8e-15) 
0 N 
20 17008 - 17229 - 74 8.3 5.65 35 
hypothetical protein 
[Chlamydomonas reinhardtii] (1.6) 
0 N 
21 17229 - 18197 - 323 36.2 5.14 52 
DNA ligase 
[Enterobacteria phage T5] (8e-85) 
0 N 
22 18231 - 18497 - 89 10.2 6.82 28 
unnamed protein product 
[Tetraodon nigroviridis] (4.3) 
0 N 
23 18497 - 18862 - 122 13.6 4.56 40 
putative bacteriophage protein; putative prohead 
protease 
[Acinetobacter baumannii AB058] (5.5) 
0 N 
24 18862 - 19095 - 78 8.8 4.42   0 N 
25 19125 - 19430 - 102 11.9 4.74 58 
hypothetical protein 
[Enterobacteria phage T5] (7e-23) 
0 N 
26 19414 - 19734 - 107 12.2 9.82 38 
hypothetical protein 
[Enterobacteria phage T5] (1e-10) 
0 N 
27 19773 - 20183 - 137 14.7 4.66 36 
D3 protein 
[Enterobacteria phage T5] (2e-11) 
0 N 
28 20262 - 21092 - 277 31.8 8.73 35 
D2 protein 
[Enterobacteria phage T5] (2e-37) 
0 N 
29 21302 - 21514 - 71 7.8 9.59 42 
similar to 60S ribosomal export protein NMD3 
[Taeniopygia guttata] (2.3) 
0 N 




[Salmonella phage E1] (2e-33) 
31 22587 – 22778 - 64 7.7 10.0 33 
phage integrase 
[Frankia sp. CcI3] (9.7) 
0 N 
32 22791 – 25580 - 930 106.8 6.23 46 
putative replication origin binding protein 
[Enterobacteria phage T5] (0.0) 
0 N 
33 26246 - 26560 - 105 12.0 6.64 35 
hypothetical protein OsI_37948 
[Oryza sativa Indica Group] (2.2) 
0 N 
34 26834 - 28987 + 718 81.0 5.31 58 anaerobic ribonucleoside triphosphate reductase 
[Vibrio parahaemolyticus 10329] (0.0) 
0 N 
35 29026 - 29238 + 71 8.3 4.94 32 
glutaredoxin 2 
[Vibrio sp. MED222] (0.071) 
0 N 
36 29238 - 30230 + 331 38.5 5.81 64 
hypothetical protein ORF027 
[Pseudomonas phage PA11] (3e-121) 
0 N 
37 30230 - 31924 + 565 63.4 5.34 68 
hypothetical protein ORF029 
[Pseudomonas phage PA11] (0.0) 
0 N 
38 31926 - 32399 + 158 18.0 7.55 63 
anaerobic ribonucleoside-triphosphate reductase 
activating protein 
[Vibrio parahaemolyticus AQ3810] (7e-50) 
0 N 
39 32486 - 32884 + 133 15.4 4.19 50 
hypothetical protein 
[Trichomonas vaginalis G3] (4.4) 
0 N 
40 32871 – 33314 + 148 17.1 9.05 38 
hypothetical protein 
[Deftia phage phiW-14] (9e-20) 
0 N 
41 33295 - 33522 + 76 8.4 7.81 39 
Aldo/keto reductase (ISS) 
[Ostreococcus tauri] (1.4) 
0 N 
42 33503 - 33961 + 153 16.9 5.92 46 
ribonuclease H 
[Enterobacteria phage T5] (4e-31) 
0 N 
43 33958 - 34158 + 67 8.0 9.90   0 N 
44 34206 - 34439 + 78 9.0 5.69   0 N 
45 34443 - 34634 + 64 7.7 6.57 36 
BcepGomrgp36 
[Burkholderia phage BcepGomr] (1.2) 
0 N 
46 34703 - 34969 + 89 10.1 4.45 53 
hypothetical protein 
[Enterobacteria phage T5] (0.22) 
0 N 




[Coraliomargarita akajimensis DSM 45221] (9.4) 
48 35313 - 35480 + 56 6.5 4.56 36 
hypothetical protein 
[Acinetobacter phage 133] (0.41) 
0 N 
49 35473 - 35736 + 88 9.9 11.51   0 N 
50 35736 - 35933 + 66 8.0 5.26 36 
hypothetical protein 
[Shigella phage SP18] (0.014) 
0 N 
51 36071 - 36316 + 82 9.7 6.28 68 
hypothetical protein 
[Vibrio phage KVP40] (5.9) 
0 N 
52 36303 - 37061 + 253 28.1 4.82 32 
phage exodeoxyribonuclease 
[Escherichia coli TA280] (5e-16) 
0 N 
53 37137 - 37331 + 65 7.2 10.76   0 N 
54 37383 - 37619 + 79 8.6 11.0   2 N 
55 37813 - 37968 + 52 5.8 11.74   0 Y 
56 39330 - 39698 + 123 14.0 9.22 35 
hypothetical protein 
[Klebsiella phage KP32] (9.0) 
0 N 
57 40243 – 40425 + 61 6.8 6.54   0 N 
58 40933 – 41337 + 135 15.2 9.12 26 
hypothetical protein 
[Vibrio phage KVP40] (0.10) 
0 N 
59 41334 - 41564 + 77 8.8 7.70 32 
hypothetical protein 
[Trichoplax adhaerens] (3.2) 
0 N 
60 42004 – 42186 + 61 7.2 10.01   0 N 
61 42571 - 42774 + 68 8.8 10.47 48 
hypothetical protein 
[Aeromonas phage Aeh1] (0.16) 
0 N 
62 42800 - 43348 + 183 20.6 4.96 41 
hypothetical protein 
[Staphylococcus carnosus subsp. carnosus TM300] 
(8e-26) 
0 N 
63 43348 - 43980 + 211 23.0 9.33 29 
nicotinamide mononucleotide transporter 
[Enterobacteria phage EPS7] (1e-10) 
6 Y 
64 44063 - 44323 + 87 9.8 4.42 35 
gp31 protein 
[Vibrio phage VP58.5] (0.018) 
0 N 
65 44316 - 44462 + 49 5.5 4.04   0 N 
66 44524 - 44829 + 102 11.4 4.62 38 
hypothetical protein SINV_00549 





67 45031 - 45225 + 65 7.6 9.73   0 N 
68 45328 – 45492 + 55 6.4 7.71   1 N 
69 45662 – 46285 + 208 23.1 6.22 34 
hypothetical protein 
[Enterobacteria phage T5] (7e-13) 
0 N 
70 46653 - 46919 + 89 10.1 9.16 46 
hypothetical protein 
[Aeromonas phage phiAS4] (3e-12) 
0 N 
71 46912 – 47283 + 124 14.3 9.00 38 
intracellular protein transport protein (UsoA) 
[Aspergillus oryzae RIB40] (7.7) 
1 Y 
72 47280 - 47573 + 98 11.4 8.42 26 
PseT.2 conserved hypothetical protein 
[Enterobacteria phage T4] (1.2) 
0 Y 
73 47563 – 48210 + 216 24.3 4.66 30 
deoxynucleoside monophosphate kinase 
[Enterobacteria phage T5] (2e-10) 
0 N 
74 48368 - 48703 + 112 12.0 4.27 37 
gp71 
[Phage phiJL001] (2e-04) 
0 N 
75 48714 - 51221 + 836 89.8 4.90 31 
hypothetical protein 
[Vibrio phage ICP2] (2e-15) 
0 N 
76 51235 - 53820 + 862 93.3 4.58 30 
hypothetical protein TU18-25_00220 
[Vibrio phage ICP3_2009_A] (0.011) 
0 N 
77 53859 - 54329 + 157 16.2 4.47 35 
hypothetical protein 
[Synechococcus elongatus PCC 6301] (9e-05) 
0 Y 
78 54314 - 54721 + 136 15.7 6.57 37 
dipicolinic acid synthetase, A subunit 
[Geobacillus sp. Y4.1MC1] (4.9) 
1 Y 
79 54679 - 55014 + 112 12.3 4.65 31 
hypothetical protein VSAK1_25885 
[Vibrio shilonii AK1] (5e-07) 
0 N 
80 55007 - 55165 + 53 5.7 3.92   0 N 
81 55162 - 55371 + 70 7.8 7.83 38 
CheA signal transduction histidine kinase 
[Geobacter lovleyi SZ] (3.5) 
0 N 
82 55595 - 56266 + 224 25.6 9.00 39 
putative holing 
[Enterobacteria phage T5] (2e-39) 
1 N 
83 56268 - 56657 + 130 14.7 9.71 58 
gp43 protein 
[Enterobacteria phage K1E] (1e-29) 
0 N 
84 56751 – 57212 + 154 17.9 7.10 30 
Metal dependent phosphohydrolase 





85 57269 – 58309 + 347 39.8 7.77 29 
possible DNA binding protein 
[Xanthomonas phage Xp15] (1e-13) 
0 N 
86 58382 - 58684 + 101 12.0 9.65 30 
tRNA-splicing endonuclease subunit sen34 
[Paracoccidioides brasiliensis Pb01] (3.3) 
0 N 
87 58704 – 58856 + 51 6.2 7.09   0 N 
88 58841 - 59047 + 69 7.7 6.02 37 
Metalloreductase 
[Cryptococcus gattii WM276] (7.6) 
1 Y 
89 59038 – 59409 + 124 14.7 5.11 26 
acetyl-CoA hydrolase/transferase 
[Eubacterium cellulosolvens 6] (0.89) 
0 N 
90 59402 – 59626 + 75 8.4 9.41 35 
conjugation system ATPase, TraG family 
[Bacteroides salanitronis DSM 18170] (0.90) 
0 N 
91 59628 - 59951 + 108 12.1 5.77 33 
(dimethylallyl)adenosine tRNA 
methylthiotransferase 
[Azoarcus sp. EbN1] (0.57) 
0 N 
92 59935 - 60153 + 73 8.8 10.61   0 N 
93 60150 – 60314 + 55 5.9 4.20   1 Y 
94 60311 - 60622 + 104 12.0 5.34 30 
hypothetical protein PTSG_05611 
[Salpingoeca sp. ATCC 50818] (1.6) 
1 Y 
95 60687 – 61925 + 413 46.2 9.14 37 
ABC transporter ATP-binding protein 
[Corynebacterium kroppenstedtii DSM 44385] 
(4.2) 
0 N 
96 61985 – 62143 + 53 6.0 9.30 33 
unnamed protein product 
[Oikopleura dioica] (7.3) 
1 N 
97 62145 – 63392 + 416 46.3 9.07 24 
conserved hypothetical protein 
[Vibrio parahaemolyticus 16] (3e-06) 
1 Y 
98 63456 – 63854 + 133 15.4 9.19 32 
periplasmic binding protein 
[Bacteroides salanitronis DSM 18170] (2.0) 
 
2 N 
99 63842 – 64243 + 134 15.4 6.65 33 
ABC transporter related protein 
[Clostridium thermocellum DSM 1313] (2.5) 
0 N 
100 64347 – 65087 + 247 28.4 5.33 32 
serine/threonine protein phosphatase 
[Enterobacteria phage T5] (8e-23) 
0 N 




[Desulfococcus oleovorans Hxd3] (9.1) 
102 65349 - 65645 + 99 11.3 4.57 38 
transcriptional regulator 
[Bradyrhizobium japonicum USDA 110] (8.0) 
0 N 
103 65632 - 66015 + 128 14.9 4.65 31 
sodium/potassium-transporting ATPase subunit 
alpha-4 
[Bos taurus] (5.5) 
0 N 
104 66056 - 66574 + 173 20.5 4.66 38 
RNA helicase, putative 
[Trypanosoma brucei gambiense DAL972] (7.1) 
0 N 
105 66571 – 66945 + 125 14.6 9.17 36 
glutamate synthase, NADH/nadph, small subunit 
[Paenibacillus polymyxa SC2] (6.2) 
0 N 
106 66942 – 67148 + 69 8.0 4.79   0 N 
107 67301 - 68263 + 321 37.0 6.36 50 
conserved hypothetical protein 
[Aeromonas phage PX29] (1e-83) 
1 N 
108 68267 – 68827 + 187 21.1 5.52 61 
hypothetical protein 
[Aeromonas phage Aeh1] (3e-54) 
1 Y 
109 68902 - 69183 + 94 11.3 4.44   0 N 
110 69183 - 69509 + 109 13.0 9.70 36 
conserved hypothetical protein 
[Candida albicans WO-1] (6.6) 
0 N 
111 69547 – 69708 + 54 6.2 6.52   1 N 
112 69755 – 70312 + 186 21.0 8.50 24 
ORF090 
[Staphylococcus phage Twort] (8.7) 
0 N 
113 70306 - 70455 + 50 5.5 9.10   1 N 
114 70457 – 71092 + 212 25.2 9.06 28 
beta-lactamase domain protein 
[Dethiobacter alkaliphilus AHT 1] (0.011) 
0 N 
115 71153 - 71485 + 111 13.4 4.19 33 
hypothetical protein 
[Enterobacteria phage 933W] (3.9) 
0 N 
116 71463 – 71714 + 84 9.9 5.63 37 
argininosuccinate lyase 
[Brevibacillus brevis NBRC 100599] (0.90) 
0 N 
117 71692 - 72018 + 109 12.3 4.29 31 
retrotransposon protein, putative, Ty3-gypsy 
subclass 
[Oryza sativa Japonica Group] (0.83) 
0 N 
118 72090 – 72470 + 127 14.6 4.29 32 
aminopeptidase P 





119 72472 - 72714 + 81 9.1 8.96 25 
unnamed protein product 
[Oikopleura dioica] (4.4) 
0 N 
120 72686 - 72910 + 75 8.9 4.47 39 
serine/threonine protein kinase 
[Methanosarcina barkeri str. Fusaro] (7.3) 
0 N 
121 72907 – 73146 + 80 9.2 6.54   0 Y 
122 73113 - 73247 + 45 5.4 8.40 48 
similar to Cytosolic carboxypeptidase 1 
(ATP/GTP-binding protein 1) 
(Nervous system nuclear protein induced by 
axotomy) 
[Ciona intestinalis] (9.4) 
0 N 
123 73514 - 74662 + 383 44.5 8.88 28 
hydrolase, haloacid dehalogenase-like family 
[Bacillus cereus G9241] (3.8) 
0 N 
124 74652 – 75011 + 120 14.4 9.40 27 
6-phosphofructokinase 
[Clostridium difficile QCD-23m63] (2.5) 
0 N 
125 75238 - 75378 - 47 5.6 10.22   0 N 
126 76295 - 76516 - 74 9.0 4.51 32 
UDP-galactopyranose mutase 
[Leishmania major strain Friedlin] (5.2) 
0 N 
127 76516 - 76710 - 65 7.8 4.51 30 
TRAP family transporter, periplasmic substrate 
binding subunit 
[Reinekea sp. MED297] (8.7) 
0 N 
128 76971 - 77288 - 106 12.0 7.86   0 N 
129 77316 - 77708 - 131 15.2 5.01 28 
chromogranin A (parathyroid secretory protein 1) 
[Monodelphis domestica] (1.0) 
0 N 
130 77805 - 78125 - 107 12.3 3.86 25 
Transketolase 
[Salinispora arenicola CNS-205] (3.4) 
0 N 
131 
 78192 - 
78314 
- 41 4.7 5.96   0 N 
132 79248 - 79718 + 157 16.8 5.07 38 
A2 protein 
[Enterobacteria phage T5] (5e-09) 
0 N 
133 79815 - 80186 + 124 13.8 9.37 25 
DEAD/DEAH box helicase, putative 
[Arabidopsis thaliana] (2.9) 
0 N 
134 80288 - 81943 + 552 61.8 6.14 31 
A1 





135 82024 - 82662 + 213 24.5 4.57 41 
5'-deoxyribonucleotidase 
[Enterobacteria phage T5] (2e-27) 
0 N 
136 82810 - 83478 - 223 25.5 8.61 28 
hypothetical protein 
[Enterobacteria phage T5] (8e-08) 
0 N 
137 83490 - 85427 - 646 72.6 9.67 30 
hypothetical protein EUBDOL_02205 
[Eubacterium dolichum DSM 3991] (2.2) 
0 N 
138 85549 - 86019 + 157 17.6 5.12 49 
hypothetical protein 
[Enterobacteria phage T5] (8e-27) 
0 N 
139 86019 - 87338 + 440 50.8 5.04 59 
terminase large subunit 
[Enterobacteria phage T5] (9e-144) 
0 N 
140 87420 - 87890 + 157 18.1 7.75 51 
hypothetical protein 
[Enterobacteria phage T5] (5e-31) 
0 N 
141 87893- 89119 + 409 46.1 5.30 51 
portal protein 
[Enterobacteria phage T5] (1e-123) 
0 N 
142 89109 - 89354 + 82 9.6 9.24 30 
hypothetical protein 
[Pyrobaculum calidifontis JCM 11548] (9.0) 
0 N 
143 89341 - 89946 + 202 22.3 4.78 54 
putative prohead protease 
[Enterobacteria phage T5] (1e-53) 
0 N 
144 89954 - 91351 + 466 51.6 5.46 60 
major head protein precursor 
[Enterobacteria phage T5] (2e-142) 
0 N 
145 91412 - 91954 + 181 20.3 5.24 22 
hypothetical protein 
[Enterobacteria phage EPS7] (7e-04) 
0 N 
146 91954 - 92700 + 249 28.3 9.95 45 
hypothetical protein 
[Enterobacteria phage T5] (1e-52) 
0 N 
147 92697 - 93182 + 162 18.9 4.86 38 
hypothetical protein 
[Enterobacteria phage T5] (1e-26) 
0 N 
148 93197 - 94612 + 472 51.7 4.68 45 
major tail protein 
[Enterobacteria phage T5] (2e-104) 
0 N 
149 94618 - 95502 + 295 32.7 6.14 29 
minor tail protein 
[Enterobacteria phage T5] (8e-17) 
0 N 
150 95499 - 95909 + 137 15.6 4.72 33 
hypothetical protein 
[Enterobacteria phage T5] (5e-16) 
0 N 







[Enterobacteria phage T5] (9e-14) 
152 96394 - 97152 + 253 27.6 5.62 27 
6-phosphogluconate dehydrogenase 





+ 1024 111.2 6.14 39 
pore-forming tail tip protein pb2 





+ 206 23.1 4.85 54 
hypothetical protein 





+ 948 106.9 5.12 46 
structural tail protein 





+ 1029 111.1 6.01 46 
tail protein Pb4 





+ 261 28.0 9.44 22 
putative phage tail protein 






Figure 3.1. Genome map of phage pVp-1. Hypothetical functions of encoded proteins were determined through comparison of amino acid 
sequences to the non-redundant databank using BLASTP. The + and – stranded ORFs were colored as grey and white, respectively. The CoreGenes 







Figure 3.2. Genome comparison of phage pVp-1 to its relative phage (T5) using Artemis 
Comparison Tool (ACT). Translated BLAST (tblastx, score cutoff: 40) was used to align translated 
genome sequences of phages. The blue lines represent the reverse and forward matches, and color 
intensity is proportional to the sequence homology. Nucleotide base-pairs were indicated between 























Recently, there has been an increasing appreciation of their role as waterborne pathogens 
of fish and humans. There has been an increasing incidence of antimicrobial resistance 
among Aeromonas sp. isolated from aquaculture environments. Multiple-antibiotic-
resistant A. hydrophila exists in aquaculture systems and contributes to the high rate of 
mortality within the fish industry in Korea. Although the majority of the loach population 
in Korea is cultured and A. hydrophila is one of the main causes of mass mortality in these 
fish, no effective method has been proposed for the control of A. hydrophila infection in 
aquaculture, except for the application of additional antibiotics. In the first step, to 
investigate methods to control the mass mortality of cyprinid loaches (Misgurnus 
anguillicaudatus) caused by multiple-antibiotic-resistant Aeromonas hydrophila on a 
private fish farm in Korea, bacteriophages (phages), designated pAh1-C and pAh6-C, were 
isolated from the Han River in Seoul. The two isolated phages were morphologically 
classified as Myoviridae and showed similar infection patterns for A. hydrophila isolates. 
The phages proved to be efficient in the inhibition of bacterial growth, as demonstrated by 
their in vitro bactericidal effects. Additionally, a single administration of either phage to 
cyprinid loaches resulted in noticeable protective effects, with increased survival rates 
against A. hydrophila infection.  
Vibrio parahaemolyticus is one of the most important causes of gastroenteritis. Although 
raw oysters have such high densities of V. parahaemolyticus that the consumption of raw 
oysters is known to cause illness in humans, almost all Koreans prefer raw oysters to 
already cooked oysters because of their fresh taste and high nutritional value. V. 




pandemics in many countries. Emergence of Vibrio species that are resistant to multiple 
antibiotics has been recognized as a serious global clinical problem. Recently isolated V. 
parahaemolyticus pandemic strains have displayed multiple antibiotic resistance, 
increasing concerns about possible treatment failure. Alternatives to conventional 
antibiotics are needed, especially for the multiple-antibiotic-resistant V. parahaemolyticus 
pandemic strain. In the second step, a bacteriophage, designated pVp-1, that was lytic for V. 
parahaemolyticus was isolated from the coast of the Yellow Sea in Korea. The phage 
showed effective infectivity for multiple-antibiotic-resistant V. parahaemolyticus and V. 
vulnificus, including V. parahaemolyticus pandemic strains. The therapeutic potential of the 
phage was studied in a mouse model of experimental infection using a multiple-antibiotic-
resistant V. parahaemolyticus pandemic strain. Phage-treated mice displayed protection 
from a V. parahaemolyticus infection and survived lethal oral and intraperitoneal bacterial 
challenges. 
In the third step, the complete genome sequence of a novel marine siphovirus pVp-1 was 
reported, which was isolated from the coastal water of the Yellow sea in Korea and infects 
V. parahaemolyticus. Genomic comparison of pVp-1 with the phage T5 revealed that these 
two phages are highly similar in gene inventory.  
Based on these results, it is clear that phages can be considered as altenative therapeutic 
or prophylactic candidates against bacterial infections in humans as well as fish. The use of 








박테리 파아지 유전체연구 및 Aeromonas hydrophila  
Vibrio parahaemolyticus에 대한 박테리 파아지 치료법 
 
2011-31100 진우 
공 보건  공 
울  과 원 
 
Aeromonas spp.는 상 인 경에 존재 는 주요 균 , 근 어  
뿐만 아니라 인간에게도 해를 는 인  병원균  주목 고 있다. 
Aeromonas hydrophila는 어 에  질병  는 운동  aeromonad  일종이며 
질병 생시 높  폐사를 야 다. 근 양식 경에  분리  Aeromonas sp.
에  항생  내  생 도  증가가 보고 고 있다. 여러 종  항생 에 
내  획득  A. hydrophila는 실  양식 경에 존재 고 있 며 국 어업에 
많  폐사를 일 키고 있다. 국내산 미꾸라지  부분  양식산이며 A. 
hydrophila는 미꾸라지 폐사  주요 원인  알  있지만, 양식산업에  A. 
hydrophila 감염증에  책  항생  여외에는 그 어떤 효과 인 책
도 없는 실 이다. 국내  어  양식장에  생  다  항생 에 내  보
이는 A. hydrophila 감염에  미꾸라지  폐사를 막   안  연구  
여, 강에  pAh1-C  pAh6-C라고 명명  리 아지 (이후 아지)




hydrophila 균주들에 사  감염 양상  나타내었다. 개  아지는 55 kb 
(pAh1-C)  58 kb (pAh6-C) 크  double-strand DNA를 보 고 있었 며, 그 
 아지  DNA는  효소 이용 분 에   다른  보 다.  
아지는 모  어 에  병원  는 A. hydrophila에 해 효과 인 균 
억  능  갖고 있는 것  드러났다.  아지  latent period는 략 30 
분 (pAh1-C)과 20 분 (pAh6-C)  찰 었고 burst size는 60 (pAh1-C)과 10 
(pAh6-C)  었다. 생체외 실험실 상에  찰  균 억  능  
에  드러난  같이, 본 아지들  균  장  효과  억 는 것
 명 었다.  미꾸라지를 상   일회  아지 여는 A. 
hydrophila 감염증에 해 목  만  어 효과를 나타내며 생존 이 크게 향
상 었다. 이러  연구 결과는 pAh1-C  pAh6-C, 이  아지가 어 에  A. 
hydrophila 감염증에  료  충분  가능  갖고 있  증명 고 
있다. 
Vibrio parahaemolyticus는 장 질  는 주요 원인체이다. 본 감염
증  불 게 조리  해산 , 특히 굴  생식과 게 어 있다. 
계  V. parahaemolyticus는 주요 감염증  원인  알  있다. 동아시
아인들, 특히 국인과 일본인  독특  식습  가지고 있다. 국인들  다
양  종  어  어 를 생식 다. 생굴  다량  V. parahaemolyticus를 함
고 있 며 생굴 취는 질병 생  험 이 있 에도 불구 고, 부분
 국인들  그 신  풍미  높  양소를 즐  여 조리  굴보다 




러 국가에  규모 식 독  원인균  알  있다. 다  항생 에 내
 보  Vibrio 균  출  심각  범 계   인식 어 다. 근 
분리  V. parahaemolyticus pandemic strain들  다  항생 에 내  나타내었
며 이는 감염 었  경우 료 실  가능 에  우 를 증폭시키고 있
다. 이에, 다  항생  내  V. parahaemolyticus pandemic strain에  항생  
체 법이 실히 요구 고 있다. V. parahaemolyticus에 감염 며 pVp-1  
명명  아지가 황해 연안에  분리 었다. 아지는 V. parahaemolyticus 
pandemic strain  포함 여, 다  항생  내  V. parahaemolyticus  V. 
vulnificus에 효과 인 감염  나타내었다. 다  항생  내  V. 
parahaemolyticus pandemic strain  이용  마우스 감염 실험 모델  용 여 본 
아지  료  가능 에 여 검증 다. 아지를 여  마우스
는 V. parahaemolyticus 감염증에 여 충분  어  보 며, 식이  복강 
주사를 통  사량에 달 는 균 감염에 도 생존  나타내었다. 본 연구
는 다  항생  내  V. parahaemolyticus pandemic strain에  아지 료  
 보고이다. 
V. parahaemolyticus에 감염 는 신규 해양 siphovirus pVp-1가 황해  연안에
 분리 었고, 이  체가 보고 었다. pVp-1  double-strand DNA 체는 
111,506 bp, 39.71%  G + C 함량  분 었다. pVp-1  체 분 에 는 
pVp-1이 T5 아지  높  체  사도를 갖고 있다는 것이 증명 었고, 
이는 pVp-1과 T5 사이   체   시사 는 것이었다. pVp-1




체 구 에 있어  높  사  보 고 있 이 시 었다. 
이러  결과를 탕 , 항생  내  A. hydrophila에 감염 는 Aeromonas 
아지가 양식 경에  Aeromonas 감염증에  료   
 충분  가능  보 고 있 이 인 었다.  V. parahaemolyticus 
CRS 09-17 균  이용  마우스 상  아지 료 실험  pVp-1 여가 V. 
parahaemolyticus 감염증 부  어를 가능 게 며, 다  항생  내  
pandemic strain에 해 야 는 규모 염병  해를 소 는데 료






Key words: Aeromonas hydrophila, 리 아지 ( 아지), Vibrio 
parahaemolyticus, 다  항생  내  pandemic strain, 료 . 
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